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ABSTRACT 
 
 The most common sexually transmitted infection for both males and females is 
the human papillomavirus (HPV).  HPV is responsible for nearly all cervical cancers.  
Currently, an HPV vaccine is available; however, HPV vaccination rates for US 
adolescents are dismal.  
School nurses serve as the person connecting medical and school communities, 
and are a critical component in assisting families traverse the medical and educational 
systems. Thus, there is reason to assume school nurses can be key opinion leaders 
regarding the HPV vaccine.   
 The purpose of this study was to: (1) explain how the Diffusion of Innovations 
(DOI) theory explains school nurses' roles as opinion leaders regarding the HPV 
vaccine; (2) document current literature regarding healthcare providers' perspectives and 
practice regarding the HPV vaccine; and (3) evaluate school nurses' knowledge, 
attitudes, perceptions of being an opinion leader and professional practice regarding the 
HPV vaccine for youth.  
 DOI states opinion leaders influence the rate of an innovation (e.g., the HPV 
vaccine). We argue school nurses are opinion leaders for the HPV vaccine because of 
their unique leadership position through their cross-disciplinary understanding of the 
educational and health systems. 
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 The systematic literature review included 28 studies of healthcare providers. The 
main barrier, vaccine cost, was identified in 12 reports. Additionally, females and older 
adolescents were more frequently vaccinated than males and younger adolescents. 
 To examine school nurses' knowledge, attitudes, perceptions and professional 
practice regarding the HPV vaccine, the study included a sample of 413 school nurses. 
Structural equation modeling revealed knowledge influenced attitudes, attitudes affected 
perceptions and professional practices, and perceptions predicted professional practice. 
Furthermore, the perceptions variable was found to be a partial mediator in the model.  
 Practitioners designing programs to engage school nurses in disseminating HPV 
vaccine education may benefit from questioning whether their programs might be 
emphasizing non-crucial elements for influencing vaccine dissemination practice (e.g., 
knowledge) and de-emphasizing influential elements such as attitudes and perceptions. 
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CHAPTER I  
INTRODUCTION 
 
 The most common sexually transmitted infection (STI) in the United States (US) 
in terms of prevalence and incidence rates for both males and females is caused by the 
human papillomavirus (HPV; Dunne et al., 2007; Giuliano et al., 2011; Weinstock, 
Berman, & Cates, 2004). The various types of HPV can be classified into two categories: 
(a) low risk—causing genital warts—and (b) high risk—causing cervical cancer 
(Ehrhardt, 2007). HPV is responsible for nearly all cervical cancers (Centers for Disease 
Control and Prevention [CDC], 2011a), which cause over 4,000 deaths in the US each 
year (American Cancer Society, 2011). HPV is also linked with 65% of vaginal cancers, 
50% of vulvar cancers, 35% of penile cancers and 90% of anal cancers (CDC, 2011a). 
Other less common illnesses associated with HPV include head and neck cancers (CDC, 
2009). When counted in tandem, 6,800 deaths in the US are linked to HPV annually 
(National Cancer Institute, 2012).  
 Currently, however, an HPV vaccine is available, and it has been shown to 
protect against most genital warts (in males and females), anal cancer (in males and 
females), and vaginal and vulvar cancers (CDC, 2011b). The HPV vaccine is nearly 
100% effective in preventing precancerous cervical, vaginal, and vulvar lesions and 
genital warts caused by the HPV types (6, 11, 16, and 18) against which the vaccine is 
directed (US Food and Drug Administration, 2010).  For the vaccine to be effective, the 
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patient must receive three doses—over a six month period—and preferably before 
becoming sexually active (CDC, 2013d).    
 Since the HPV vaccine was approved in the US during 2006 (for females) and 
2009 (for males), 53% of US female teens (13-17 years) have been vaccinated with the 
first of the three required doses. Furthermore, 34.8% of US adolescent females have 
received all three recommended doses (CDC, 2012a).  In 2011, US male teens’ HPV 
vaccination rates were estimated to be 8.3% with the first of three required doses (CDC, 
2012a).  These rates are far from the Healthy People 2020 objective of 80% coverage for 
females 13-15 years and no percentage targeted for males (US Department of Health and 
Human Services, 2012).  
Low HPV vaccination acceptance factors include lack of appropriate and 
adequate information about the HPV vaccine from healthcare professionals (Nagaraj, 
2006; Serpell & Green, 2006), parents’ belief the HPV vaccine would promote 
promiscuity, parents’ and children’s concerns about vaccine safety and possible side 
effects (allergic reactions, fever, headache, or fainting; CDC, 2012b; Mathur, Mathur, & 
Reichling, 2010), and trust in authorities recommending the vaccine (Kimmel, 2006). 
These low HPV vaccination rates indicate a divide between the availability of a vaccine 
and its acceptance and uptake by youth.  
 Wide-spread acceptance of the HPV vaccine relies on various stakeholders: the 
adolescents, their parents, and healthcare providers. In a recent study, adolescents rated 
parents, doctors, or nurses as their most important source of HPV vaccine information 
(Mathur et al., 2010). Studies are also finding that, when assessing parents’ role in HPV 
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vaccine acceptance, parents are more likely to vaccinate their child if the parent believes 
his/her doctor would recommend the child receive the HPV vaccine (Boehner, Howe, 
Bernstein, & Rosenthal, 2003; Davis, Dickman, Ferris, & Dias, 2004; Dempsey, Zimet, 
Davis, & Koutsky, 2006; Gerend, Lee, & Shepherd, 2006; Kahn et al., 2003; Kahn, 
Rosenthal, Hamann, & Bernstein, 2003; Olshen, Woods, Austin, Luskin, & Bauchner, 
2005). Other factors influencing parents’ HPV vaccination acceptance include being 
influenced by peer groups, parent perceiving the child is susceptible to HPV infection, 
and having had personal experience with genital warts (Dempsey et al., 2006). Lastly, a 
literature review focusing on physicians and the HPV vaccine showed that while most 
physicians were knowledgeable about HPV infections (Bartlett & Peterson, 2011), the 
reasons they did not recommend the vaccine included prior experience with parent 
refusal for younger child and the amount of time needed to discuss vaccine with parents. 
Physicians also perceived parents’ rationale for refusing the vaccine to include unknown 
long-term side effects and absence of sexual activity by daughters (Bartlett & Peterson, 
2011).   
 Given the various stakeholders and their equally varied reasons for accepting or 
rejecting the HPV vaccine, campaigns to increase vaccination rates may be more 
successful if they include an endorsement of HPV vaccination by trusted individuals and 
promotion of the vaccination as a social norm (Conroy et al., 2009). Because they are 
perceived as trustworthy, have professional knowledge, interact daily with school-aged 
youth, and exert leadership roles in the communities they serve, school nurses represent 
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invaluable stakeholders in disseminating information about and the uptake of the HPV 
vaccine among youth.  
School nurses serve as the person connecting the medical and school 
communities, and therefore, are a critical component in assisting parents and students 
attempting to traverse the medical and educational systems (American Academy of 
Pediatrics Council on School Health, 2008). The literature indicates  students and school 
communities are healthier if they employ school nurses (Baisch, Lundeen, & Murphy, 
2011; Canham et al., 2007; DeSocio & Hootman, 2004; Ethan & Basch, 2008; Farris, 
McCarthy, Kelly, Clay, & Gross, 2003; Ficca & Welk, 2006; Gutt, Engelke, & Swanson, 
2004; Johnson & Hayes, 2006; Moonie, Sterling, Figgs, & Castro, 2008). For schools 
that do employ a nurse, he/she acts as the onsite healthcare provider (American 
Academy of Pediatrics Council on School Health, 2008), especially for students who do 
not have consistent access to healthcare. Additionally, there is evidence supporting 
schools with nurses have higher vaccination rates for other recommended vaccines 
(American Academy of Pediatrics Council on School Health, 2008). Thus, there is 
reason to assume school nurses can be key opinion leaders regarding the promotion of 
HPV vaccination for youth.  
 Due to their salient roles, as well as their linking of the medical and school 
communities, there is a need to understand school nurses as opinion leaders regarding 
the HPV vaccination rates in youth. However, while school nurses are the most readily 
available healthcare professional to families with adolescents (Bennett, 2008), no study 
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has yet explored school nurses’ role in increasing HPV vaccination rates and educating 
parents and students about the HPV vaccine’s benefits.  
 The purpose of this dissertation is to provide empirical evidence of US school 
nurses’ knowledge, attitudes, professional practice, and perceptions of role as opinion 
leader regarding the HPV vaccine for youth. More specifically, this dissertation will: (1) 
Discuss the theory utilized to guide this research project and how the theory explains  
school nurses' role as opinion leaders regarding the HPV vaccine for youth; (2) 
Document and assess current literature regarding healthcare providers' knowledge, 
attitudes, perceptions, intentions, and professional practice regarding the HPV vaccine 
for youth; and (3) Provide results from a quantitative online survey measuring school 
nurses’ knowledge, attitudes, professional practice, and perceptions of role as opinion 
leader regarding HPV vaccine for youth. This innovative study will provide in-depth 
information about school nurses’ knowledge, attitudes, perceptions and professional 
practice regarding HPV vaccine for youth, which, can be used to develop and implement 
appropriate vaccination campaigns for youth in the US. 
 This dissertation is comprised of five chapters. Chapters II-IV represent 
manuscripts that will be submitted to peer-reviewed journals for publication. The 
following is a description of each chapter: 
 Chapter I provides an overview of the topic being examined throughout this 
document. Additionally, the purpose, significance, and innovation of the research 
project are outlined.  
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 Chapter II presents the Diffusion of Innovations theory (DOI) being utilized to 
guide this research project. This chapter also focuses on examining school nurses 
as opinion leaders within the DOI and how DOI is a useful theory to assess 
school nurses’ role in promoting the HPV vaccine for youth. This chapter 
represents the first journal article. 
 Chapter III documents the current literature regarding healthcare providers’ 
knowledge, attitudes, perceptions, intentions, and professional practice regarding 
the HPV vaccine for youth. This review of the literature follows a systematic 
literature review framework (Garrard, 2010). In addition, this chapter documents 
the gap in research assessing school nurses’ knowledge, attitudes, and 
professional practice regarding the HPV vaccine for youth. This chapter 
represents the second journal article. 
 Chapter IV reports on quantitative findings from an online survey distributed to 
members of the National Association of School Nurses. The report examines a 
sample of 413 school nurses’ knowledge, attitudes, and professional practice 
regarding the HPV vaccine for youth. Findings identifying school nurses' 
perceptions of their role as opinion leaders regarding the HPV vaccine for youth 
are provided. This chapter represents the third journal article. 
 Chapter V presents the conclusions reached by examining the theory and 
evidence found in chapters II-IV. Implications for health education, school 
health, and school nursing fields are discussed, and recommendations for future 
research are provided. 
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CHAPTER II 
A RECOMMENDATION TO USE THE DIFFUSION OF INNOVATIONS THEORY 
TO UNDERSTAND SCHOOL NURSES' ROLE IN HPV VACCINE UPTAKE 
 
Introduction 
Diffusion theory does not lead to the conclusion that one must wait for the 
diffusion of a new product or practice to reach [specific population groups] . . . . 
In fact, one can accelerate the rate of adoption in any segment of the population 
through more intensive and more appropriate communication and outreach. 
(Green, Gottlieb, & Parcel, 1991, p. 114) 
  
Medical prevention is considered more economical than treatment (Rogers, 
2002), and this is true for vaccinations. In 1999, the Centers for Disease Control and 
Prevention (CDC) named vaccinations as one of the century’s greatest public health 
achievements (CDC, 1999). Nearly 14 years later, in 2013, CDC released an updated 
immunization schedule for adults, infants/children, and adolescents (CDC, 2013d). 
 While adolescents receive most required or recommended vaccines, the Human 
Papillomavirus (HPV) vaccination rates remain low among US teenagers (CDC, 2012a).  
Since its approval in 2006 (for females) and 2009 (for males), 53% of female teens have 
been vaccinated with the first of the three required doses. Furthermore, only 34.8% of 
adolescent females have received all three recommended doses. Males three dose 
vaccination rates are currently not reported (CDC, 2012a).  
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 The HPV vaccine helps protect against certain sexually transmitted infections 
and cancers. Two vaccines (Cervarix and Gardasil) protect females against HPV strains 
causing most cervical cancer cases (CDC, 2013c). Gardasil also protects against most 
genital warts (in males and females), anal cancer (in males and females), and vaginal and 
vulvar cancers. However, the vaccine provides the greatest benefit only when all three 
doses are received before the person becomes sexually active (CDC, 2013c). If the HPV 
vaccine confers health benefits, but HPV vaccination rates remain low, how can we, as 
health educators, more effectively diffuse and implement support for the HPV vaccine 
and, ultimately, increase the HPV vaccination rates among youth?  
 Although the solution to this vaccine uptake problem is complex, non-linear, and 
multifaceted (Roux, 2011), one component includes identifying and examining how 
HPV vaccination behaviors may spread through populations. Specifically, examining 
how opinion leaders influence the vaccine’s diffusion may be a helpful first step. 
While much of the US health promotion literature has examined physicians, 
pediatricians, and other healthcare providers’ knowledge, attitudes, intentions, and 
professional practice regarding the HPV vaccine, none has empirically explored US 
school nurses’ role in helping educate the school community about the HPV vaccination 
benefits. To date, it appears researchers and practitioners have failed to include all 
opinion leaders in the study of the HPV vaccine diffusion process (see Chapter III).  
While US school nurses have been conspicuously absent from health promotion 
research, recent studies in the United Kingdom and Sweden have examined school 
nurses’ perceptions and experiences of implementing a government-mandated HPV 
 9 
 
vaccination program. Those studies have shown that non-US school nurses’ perceptions 
or experiences included positive attitudes regarding the HPV vaccine as a preventive 
health measure (Boyce & Holmes, 2012; Gottvall, Tyden, Larsson, Stenhammar, & 
Hoglund, 2011; Hilton, Hunt, Bedford, & Petticrew, 2011), concerns about fitting the 
immunization tasks into their already demanding schedules (Boyce & Holmes, 2012; 
Gottvall et al., 2011; Hilton et al., 2011), and insecurity about their knowledge of the 
HPV vaccine (Gottvall et al., 2011).  
To examine the potentially positive role school nurses might play in 
disseminating knowledge and promoting vaccination behavior among US teenagers, we 
propose adopting the Diffusion of Innovations theory (DOI) as a framework. Thus, this 
article’s purpose is to identify how the DOI theory can help us understand school nurses’ 
HPV vaccine knowledge, attitudes, perceptions of role as opinion leader, and 
professional practice, which in turn can help increase youths’ HPV vaccination rates. As 
Rogers—the main theorist behind DOI—reminds us, “The success or failure of diffusion 
programs rests in part on the role of opinion leaders” (Rogers, 2003, p. 99).   
Theoretical Review 
 Researchers in multiple disciplines have utilized the DOI theory for almost a 
century, focusing on topics ranging from agricultural techniques to birth control, and 
public education to health education programs (Ferrence, 2001). This theory is unique as 
it describes the process of change at many levels over time, while incorporating other 
theories such as Social Cognitive Theory and Communications Theory, to offer a better 
understanding of the diffusion phenomenon (Ferrence, 2001). 
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The DOI theory, as developed and refined by Everett M. Rogers, owes its 
beginnings to studies carried out by Gabriel Tarde. According to Rogers, Tarde “was a 
Frenchmen lawyer and judge around 1900 who kept an analytical eye on trends in his 
society as presented by the legal cases that came before his court” (Rogers, 2003, p. 14). 
Tarde wanted to understand the reasons why some innovations spread and others were 
forgotten. He noticed an innovation's adoption rate followed an S-shaped curve over 
time, and the adoption takeoff started with opinion leaders using the innovation (Rogers, 
2003). Tarde’s theory characterizes social imitation as an epidemic (Ferrence, 2001), and 
an idea, much like a virus, spreading from one person to another through contagion 
(Gladwell, 2002). 
To understand the role opinion leaders play in the process of spreading a new 
idea or a new practicein our case, examining school nurses' roles in HPV vaccination 
rateswe need to understand the diffusion process itself. Diffusion of information or 
innovations is a process “by which (1) an innovation (2) is communicated through 
certain channels (3) over time (4) among the members of a social system” (Rogers, 2003, 
p. 11). Opinion leaders are members within a social system that communicate with and 
influence other members about the innovation over a certain time period. As Rogers 
(2003, p. 11) claims, “These elements are identifiable in every diffusion research study 
and in every diffusion campaign or program.” To understand opinion leaders’ role in the 
diffusion process, it is important to examine the theory’s constructs of innovation, 
communication channels, social systems, and time. 
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Innovation 
 Innovation is the first component in the DOI theory and Rogers (2003) defines 
innovation as an idea, practice, or object an individual perceives as new. The “newness” 
of the innovation is not based on lapse of time from when the person discovers the 
innovation. Rather, if the idea appears new to the individual it is considered an 
innovation. If the idea is perceived as new, this perception will determine the 
individual’s reaction to the idea. Therefore, the “newness” is not restricted to the 
individual’s new knowledge of this innovation. Someone may have prior knowledge 
about the innovation, but he/she may not yet have developed an attitudewhether 
favorable or unfavorabletoward the innovation. An innovation’s “newness” may not 
only be represented based on knowledge, but also in terms of the attitude or decision to 
use that innovation (Rogers, 2003). 
 Five characteristics of an innovation determine its rate of adoption: (1) relative 
advantage, (2) compatibility, (3) complexity, (4) trialability, and (5) observability 
(Rogers, 2003; Rogers, 2002). Relative advantage is known as whether the innovation is 
perceived as superior when compared to the previous idea and is considered 
advantageous. Compatibility refers to the innovation being viewed as consistent with 
potential adopters’ existing values, past experiences, and needs, while complexity 
alludes to the degree to which an innovation is perceived as challenging to understand 
and use. If an innovation can be experimented with, it is considered to have trialability. 
Observability is measured by the degree to which the innovation's effects are visible to 
other people (Rogers, 2003; Rogers, 2002). 
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 More specifically, when examining prevention innovationsdefined as new 
ideas requiring action to avoid unwanted consequences at a future time (Rogers, 2003) 
the reward from adopting a prevention innovation is often deferred to a later date or, 
sometimes, not at all.  The prevented event did not occur, and thus, is not countable or 
observable. For example, the HPV vaccine protects individuals from certain HPV 
strains, a behavior unseen to the adopters, meaning they have trouble “seeing” this 
outcome. Therefore, when compared to non-prevention innovations, prevention 
innovations have slow rates of adoption (Rogers, 2003). 
Given that prevention innovations (such as the HPV vaccine) may not exhibit 
characteristics that facilitate quick adoption, what methods can be utilized to increase 
their adoption rates? Rogers (2002) suggests employing champions (i.e., opinion leaders) 
who can exert personal influence to encourage the vaccine's adoption. Additionally, 
activating peer networks also can help diffuse the vaccine. By encouraging peer 
communication regarding the vaccine, people in the social network will begin talking 
about the HPV vaccine, thereby giving it meaning, which can, over time, lead to 
adoption (Rogers, 2002). 
Communication Channels   
Communication channels are vital to the diffusion process and consist of 
methods employed in passing along a message from one person to another (Rogers, 
2003), what many diffusion researchers refer to as a social process (Dearing, 2009).  
Although knowledge can be obtained through a one-way communication method—
particularly with searching capabilities of new communication technologies—persuasion 
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toward adopting a new idea actually occurs via a two-step flow communication model. 
Persuasion in the two-step flow model comprises local informal opinion leaders, who are 
in the center of the social networks, spreading their knowledge, views, and behaviors 
outward, through the network (Dearing, 2009). 
Diffusion of Innovations researchers have tested the two-step flow model 
extensively and it has proven useful for understanding communication flow within the 
context of communication channels. In this model, the initial step comprises a media 
source (e.g., radio, print, mass media) transferring information to an opinion leader (Katz 
& Lazarsfeld, 1955; Rogers, 2003), who is then influenced by the media source (Katz & 
Lazarsfeld, 1955). Information is then filtered by the opinion leader and translated to 
his/her followers (Katz & Lazarsfeld, 1955; Rogers, 2003). During the second step, not 
only is information spread, but so is the opinion leader’s interpersonal influence. Simply 
put, a message flows from mass media, to opinion leaders, to their followers (Rogers, 
2003)but it does not flow in its “pure” original state. Once the message reaches the 
followers, it has been shaped by the opinion leaders’ own views and experiences with 
the innovation. 
However, the communication process does not always involve two steps (Rogers, 
2003). When mass media directly influences a person’s adoption of the innovation, there 
may only be one-step. Other cases may involve multiple stages in the transmission of 
information (Rogers, 2003; Waldrop, 1992).  
According to the DOI theory, mass media channels are more successful in 
creating innovation knowledge, while interpersonal channels are more effective in 
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developing and altering attitudes toward an innovation (Rogers, 2003; Rogers, 2002), 
thereby affecting people’s decision to accept or discard a new idea (Rogers, 2002). Mass 
media involves transmitting messages via broadcast media such as radio, television, 
newspapers, social media, and the Internet.  Interpersonal communication, according to 
the theory, is a face-to-face exchange between people.  Most people evaluate an 
innovation, not through scientific research conducted by experts, but through the 
subjective assessment of the innovation by “near peers”—role models whose behavior 
tends to be copied by others in their social system (Rogers, 2003; Rogers, 2002). In other 
words, diffusion is a social phenomenon that occurs as people talk to other people, 
spreading a new idea (Rogers, 2002). 
When an innovation is perceived to be risky, information in Web sites, 
presentations, brochures, training workshops, and one-on-one counseling appears to lack 
the necessary elements to move people away from uncertainty, towards a positive 
decision (Bero et al., 1998; Lomas et al., 1991; Thompson, Estabrooks, & Degner, 
2006). In order to increase positive decisions, as well as to assist in reasoned judgments 
and empirical decision making, a dual-method intervention that utilizes both the 
information channels—mass media—and influential channels (Bandura, 1997)—opinion 
leaders—is needed (Saladek, Phillips, & Bond, 2006). 
Because opinion leaders act as influential channels and have the ability to 
communicate positive health messages (Green, Ottoson, Garcia, & Hiatt, 2009; Valente 
& Pumpuang, 2007), school nurses can be considered influential channels. For example, 
research findings showed nurses had stronger attitudescompared to school personnel 
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without healthcare trainingtowards vaccines’ use and safety and these attitudes were 
associated with lower vaccine exemption rates in the school (Salmon et al., 2004).  These 
results suggest school nurses’ communicate their attitudes about vaccines, which in turn 
possibly influence vaccination behaviors. School nurses, therefore, obtain health 
information about risky innovations (e.g., HPV vaccine) and shape the information, 
adapting it to various audiences. 
Social Systems 
Diffusion of Innovations theory defines social systems as sets of interrelated 
groups of people involved in problem solving to reach a common goal (Rogers, 2003). 
All system members contribute to finding solutions to a common problem/issue. Social 
systems are included in the DOI theory because diffusion occurs inside a social system 
and the system’s structure affects the diffusion process and outcomes. The social system 
represents “boundaries” within which an innovation will (or will not) diffuse (Rogers, 
2003). 
For over 50 years, scholars have noted the impact of interpersonal relationships 
on adoption behaviors (Valente, 1995; Valente & Davis, 1999), especially relationships 
with opinion leaders in a system. Social systems incorporate opinion leaders who 
frequently influence other people's attitudes or behaviors (Rogers, 2003). Opinion 
leaders—also referred to as champions, lay health advisors, health advocates, and 
community leaders (Valente & Pumpuang, 2007)—provide information and advice 
about innovations to other members of the social system. According to the DOI theory, 
to become and remain an opinion leader, the person must be competent, accessible, and 
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conform to that particular system's norms. By conforming to social norms, opinion 
leaders provide a model for the innovation’s acceptance or rejection (Rogers, 2003). 
Being perceived as an opinion leader allows the leader to remove barriers and increase 
the rate of diffusion (Valente & Davis, 1999). Diffusion within interpersonal networks 
considers both principles of learning theory (Bandura, 1986) and diffusion (Rogers, 
2003; Valente, 1993; Valente & Rogers, 1995); learning is most efficient when people 
are taught or trained by near peers selected to be models of that behavior (Rice, 1993). 
 DOI theory characterizes opinion leaders as those who experience: (1) greater 
exposure to mass media, (2) greater contact with change agents, (3) higher 
socioeconomic status and (4) greater social participation (Rogers, 2003).  Although 
opinion leaders tend to have higher socioeconomic status than their followers, the most 
notable characteristic is their influential role in the communication structure. Because 
socioeconomic status allows broader access to various social groups, opinion leaders 
engage in face-to-face communication about new ideas at formal meetings and informal 
discussions more often than their followers. Opinion leaders find themselves, therefore, 
at the center of interpersonal communication networks in the diffusion process (Rogers, 
2003).  
 Opinion leaders’ importance in the diffusion process has been documented in 
numerous studies and experiments reporting how opinion leaders foster behavior change 
related to HIV prevention, adoption of mammography, and prevention of heart disease, 
among others (Rogers, 2003). Because they have demonstrated impact on health 
improvement (Rogers, 2003), opinions leaders have been utilized to gain support in 
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public health and community health programs (Valente & Pumpuang, 2007). Opinion 
leaders have been used to implement programs because when there is uncertainty 
regarding an innovation, people tend to search for information and evaluative judgments 
from trusted and respected people in the social system (Dearing, 2009). Opinion leaders 
encourage others to know about the innovation and know where to direct followers to 
receive more information (Dearing, 2009). Thus, identifying and utilizing opinion 
leaders can contribute substantially to enhancing the diffusion process within health 
services.   
School nurses can be considered opinion leaders because of their role and 
position within schools. School nurses are opinion leaders that function across multiple 
social systems such as hospitals (Soumerai et al., 1998) and schools (Valente, Hoffman, 
Ritt-Olson, Lichtman, & Johnson, 2003) because they have greater contact with change 
agents (e.g., physicians or clinicians) and social participation.  School nurses are 
considered connectors between healthcare professionals, students, parents, school staff, 
and communities (American Academy of Pediatrics Council on School Health, 2008). 
This connector status provides school nurses with access to various social groups and 
places school nurses in the center of interpersonal communication networks regarding 
school health issues and concerns.  
Time 
In much of the behavioral science research, timeas a focal variableis often 
neglected. In the DOI theory, it is the fourth crucial element characterizing the diffusion 
process (Rogers, 2003). Time affects the following three processes: (1) the innovation-
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decision process, (2) a person or unit's innovativeness, and (3) an innovation's rate of 
adoption.  For the purposes of our argument, we will only discuss how time influences 
the innovation-decision process. To explore the concepts of unit innovativeness and rate 
of adoption further, see Rogers, 2003.  
The innovation-decision process begins with knowing about the innovation and 
ends with accepting or rejecting it (Rogers, 2003). This process includes five steps in a 
time ordered-sequence: (1) knowledge, (2) persuasion, (3) decision, (4) implementation, 
and (5) confirmation. Knowledge occurs when a person learns of the innovation and 
understands its function. In persuasion, the person is coaxed into developing a favorable 
or unfavorable attitude towards the innovation. Implementation occurs when the person 
uses the innovation. Re-invention, a change in the innovation by the users, can take place 
during the implementation stage. Confirmation occurs when a person attempts to find 
support for the already-made decision to adopt the innovation. At any time, nonetheless, 
the person may change his/her previous decision if exposed to conflicting information 
about the innovation (Rogers, 2003).   
The innovation-decision period is the time needed to move through these five 
steps (Rogers, 2003). People differ in the time required to go through the process, with 
some taking many years to adopt an innovation while others move rapidly.   
During the knowledge and persuasion stages, communication channels play a 
vital role. At the knowledge stage, a person wants to know about the what, how, and why 
of the innovation (Rogers, 2003). Mass media communication channels are more 
effective in providing general information during the knowledge stage. Then, during the 
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persuasion stage, a person wants to know the innovation’s advantages and disadvantages 
for him/her, in particular. Near peersinterpersonal communicatorsare people who 
provide personal assessments of the innovation. Because mass media provide a “one-
size-fits-all” message about the innovation, it is not as beneficial in the persuasion stage 
as evaluations from near peers, whose opinion can influence adopters’ choices at both 
the decision and confirmation stages (Rogers, 2003). 
More specifically when examining the HPV vaccine, literature reviews reported 
knowledge of HPV to be low in the general population (Brewer & Fazekas, 2007; 
Gamble, Klosky, Parra, & Randolph, 2010; Herzog, Huh, Downs, Smith, & Monk, 2008; 
Jenson, 2009; Kollar & Kahn, 2008; Zimet, 2006). If knowledge about the disease is 
low, more often than not, knowledge about the vaccine will also be low. However, to 
increase knowledge and positive attitudes towards the HPV vaccine, school nurses can 
provide education and professional assessment of the HPV vaccine to parents and 
students still forming attitudes about the new vaccine. Because “one-size-fits-all” health 
messages may not be effective in behavior change (Kollar & Kahn, 2008), school nurses 
can provide tailored messages to parents and students. 
Implications for School Health 
 To address the low HPV vaccination rates among youth in the US, we argue 
school nurses can function strategically as opinion leaders within the school system, thus 
providing a solution to increase these rates.  In exploring school nurses’ role as opinion 
leaders, Burt (1999) further adds that opinion leaders are not merely leaders within a 
system, but also a broker among groups in a system. School nurses are liaisons among 
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students, school staff, healthcare professionals, families and communities (American 
Academy of Pediatrics Council on School Health, 2008). Thus, school nurses function as 
informal interpersonal communication channels among multiple academic and medical 
sources, parents, and students.  
 School nurses possess a special type of leadership position, as they are able to 
influence both policies and programs due to their cross-disciplinary understanding of 
educational and health systems (Baisch et al., 2011; American Academy of Pediatrics 
Council on School Health, 2008). Such leadership commonly extends to providing input 
and making decisions about health education curriculum, as well (American Academy of 
Pediatrics Council on School Health, 2008). Because school nurses represent the 
healthcare system (to parents and students), they are positioned to assist parents not only 
with education about health, but also with decisions regarding their children’s healthcare 
(Baisch et al., 2011; American Academy of Pediatrics Council on School Health, 2008).  
In addition to understanding school nurses’ roles as opinion leaders, it is 
important to understand their views of the HPV vaccine for youth, because—as 
described above—opinion leaders’ attitudes affect the diffusion process (Rogers, 2003). 
To understand school nurses’ attitudes, their role in the persuasion stage of the 
innovation-decision process must be examined. According to the theory, it is during this 
stage that school nurses develop favorable or unfavorable attitudes towards the HPV 
vaccine. They use their own communication channels (other school nurses, doctors, and 
clinical nurses) to develop these attitudes. Once an attitude is formed, there is an 
assumption that behavior will follow: the HPV vaccine will be accepted or rejected, 
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according to whether the attitude is favorable or unfavorable.  However, congruence 
between attitude and behavior is not always the case; the behavior may be dissimilar to 
the attitude. This is not uncommon regarding many preventive health innovations, such 
as contraceptives (Rogers, 2003). This discrepancy is known as the KAP-gap (KAP 
refers to knowledge, attitudes, and practice; Rogers, 2003) and, to date, school nurses’ 
KAP-gap as well as their perceptions of their role as opinion leaders have not been 
systematically examined. 
 In order to address this deficiency in the current literature, it is important to, first, 
understand school nurses’ role, theoretically. For this, the DOI theory provides a useful 
lens through which researchers and practitioners in health promotion can comprehend 
the vaccine dissemination process and engage school nurses in the efforts to promote 
HPV vaccine for youth. 
Limitations   
 Although useful, the DOI framework suffers from important limitations. Among 
these are DOI’s inherent biases, such as a pro-innovation and individual-blame bias 
(Rogers, 2003). The assumption underlying the theory and most of the research 
employing DOI theory is that all members of a given system should or will adopt an 
innovation and the innovation should not be rejected nor re-invented. This can be a 
problematic assumption, leading to diffusion researchers underemphasizing rejection, 
ignoring re-invention, and failing to examine anti-diffusion programs. Due to this 
inherent bias, researchers know more about innovation success than failures (Rogers, 
2003).    
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 The pro-innovation bias is an important limitation to recognize because within 
this article we have made the assumption certain opinion leadersspecifically, school 
nursesshould support and promote HPV vaccination for adolescents. However, this 
proposition is unlikely to be true for all school nurses, and in some cases might not even 
be feasible. Research is important to determine school nurses’ views of the vaccine as an 
innovation, and their support (or lack thereof) for the HPV vaccine.  
Individual-blame bias, on the other hand, is the inclination to blame people for 
difficulties during diffusion, rather than faulting the system. As Rogers reminds us, 
individual-blame bias is reflected in the saying, “If the shoe doesn’t fit, there is 
something wrong with your foot” (2003, p. 119). However, a more fruitful strategy 
might be to examine the systems, not the individual, when searching for breakdowns in 
the diffusion process. This different point of view might reveal the “shoe manufacturer 
or the marketing system could be at fault for the shoe that does not fit” (Rogers, 2003, p. 
119).  
 Individual-blame bias is, potentially, the most important limitation that our 
argument for using the DOI theory faces. When researchers focus on understanding 
school nurses’ role in the HPV vaccination uptake for youth, they (the researchers) are 
tempted to ignore contextual or systemic factors that might be at play, such as policies, 
legislation, or even availability of resources. For example, some states have legislation 
prohibiting school nurses from recommending non-mandated vaccinations. If school 
nurses do recommend vaccines, school districts may be held accountable for the 
vaccine’s cost.  In addition, not all schools have the resources to provide HPV 
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vaccination education and information to parents and students, regardless of the efforts 
their nurses exert. Therefore, when examining school nurses as opinion leaders, 
researchers also must be sensitive to this potential bias.   
Conclusion 
 Despite inherent limitations, we believe DOI theory offers a fruitful, elegant 
narrative for understanding and engaging school nurses as opinion leaders for promoting 
the HPV vaccine among youth. Why there have not been concerted attempts to 
understand and involve US school nurse populations remains a mystery. 
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CHAPTER III 
HEALTHCARE PROVIDERS AND THE HPV VACCINE: A SYSTEMATIC 
REVIEW 
 
Introduction 
 Vaccinations were named by the Centers for Disease Control and Prevention 
(CDC) in 1999 as one of the 10 greatest public health achievements of the century. 
Despite the magnitude of vaccination’s health achievements, some vaccines have 
encountered less-than-enthusiastic responses and acceptance from various populations.  
 While some vaccinations for children and adolescentsTd (tetanus-diphtheria) 
or Tdap (tetanus-diphtheria-pertussis), MenACWY (meningococcal conjugate), and 
Varicella (chicken pox)are well received, with uptake rates of 78%, 71%, and 68% 
respectively, the Human Papillomavirus (HPV) vaccination rates remain relatively low 
among teenagers in the United States (US; CDC, 2012a). Since its approval in 2006 (for 
females) and 2009 (for males) by the Food and Drug Administration (FDA), only an 
estimated 53% of female teens and 8% of male teens have been vaccinated with the first 
of the three required doses. Furthermore, an estimated 35% of adolescent females have 
received all three recommended doses (CDC, 2012a).  
 HPV, the most common sexually transmitted infection (STI), has affected an 
estimated 79 million Americans by 2013 while approximately 14 million will become 
infected with the virus, annually (CDC, 2013b). Furthermore, 75% of these new HPV 
cases will occur in people aged 15-24 (Weinstock et al., 2004). In particular, 45% of 20-
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24 year old females were estimated to be infected with HPV in 2007, with 14-19 year 
old girls having a high likelihood of acquiring HPV (Dunne et al., 2007).  
 HPV is extremely common and linked with nearly all cases of cervical cancer 
(World Health Organization, 2009); however, the HPV vaccine helps protect against 
HPV and HPV-related cancers. Currently, there are two vaccines (Cervarix and 
Gardasil) to protect against the HPV strains causing most cervical cancer cases (CDC, 
2013c). Gardasil has also been shown to protect against most genital warts (in males and 
females), anal cancer (in males and females), and vaginal and vulvar cancers. However, 
the vaccine provides the greatest benefit if a person receives all three doses and develops 
an immune response before sexual initiation, which is the reason the vaccine is 
recommended for preadolescent boys and girls (CDC, 2013c). While the HPV vaccine 
confers obvious health benefits, vaccination rates remain low for adolescents in the US.  
 Even though there are low vaccination rates among adolescents, numerous 
agencies and organizations have published objectives and recommendations to increase 
HPV vaccination rates. Healthy People 2020 included an objective to increase the three 
dose HPV vaccine uptake among femalesages 13-15 yearsfrom 23% in 2009 to 
80% by 2020 (US Department of Health and Human Services, 2012). Along with the 
FDA, in 2006 the Advisory Committee on Immunization Practices (ACIP) 
recommended girls 11-12 years old routinely receive the HPV vaccine, and 13-26 year 
old women receive the vaccinein order to “catch up”to prevent cervical, vaginal, 
and vulvar cancers (CDC, 2010a; CDC, 2010b).  The HPV vaccine recommendation has 
received support by other national health agencies and professional organizations 
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including, but not limited to, American Academy of Pediatrics (Committee on Infectious 
Diseases, 2007), National Cancer Institute, CDC (CDC, 2007) and National Association 
of School Nurses (Burch, Inderbitzin, Robarge, & Zacharski, 2010).  
 However, recommendations and support from national health agencies and 
professional organizations do not guarantee vaccine acceptance by the public. In fact, 
multiple factors affect adolescents’ vaccination rates including the adolescents 
themselves, their parents, and healthcare providers. Previous literature reviews have 
summarized findings concerning adolescents’ and parents’ HPV vaccine knowledge, 
attitudes, and perceptions (Brewer & Fazekas, 2007; Dempsey & Zimet, 2008; Jenson, 
2009; Kessels et al., 2012; Kollar & Kahn, 2008). Few reviews have included healthcare 
providers in addition to adolescents and parents (Bartlett & Peterson, 2011; Fisher, 
Darrow, Tranter, & Williams, 2008; Gamble et al., 2010; Herzog et al., 2008; Zimet, 
2005; Zimet, 2006). However, less attention has been paid exclusively to healthcare 
providers and health educators, their views and practice regarding the HPV vaccine for 
youth. 
 Thus, the purpose of this review is to systematically summarize and empirically 
examine the scientific research literature examining healthcare providers and health 
educators, their knowledge, attitudes, and professional practice concerning the HPV 
vaccine among youth. For this review, healthcare provider was defined as an individual 
qualified to provide and deliver healthcare (e.g., pediatricians, physicians, clinical 
nurses, school nurses). Health educator was defined as a person who promotes, helps 
maintain and improve both individuals’ and communities’ health through support for 
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engaging in healthy behaviors (US Department of Labor Bureau of Labor Statistics, 
2009). Additionally, the reviewed literature was examined for methodology quality, 
including use of theoretical frameworks and statistical analytic methods. Describing 
methodological quality is vital because such description captures the literature's overall 
strength and allows the reader to draw conclusions about the generalizability and biases 
in findings (Schulz, Chalmers, Hayes, & Altman, 1995). 
 Systematic literature reviews allow researchers to identify and map previous 
studies in a systematic manner (Bennett, Lubben, Hogarth, & Campbell, 2005). Through 
mapping the literature, researchers can disseminate findings from several studies, 
establish evidence-based practices, and provide a basis for future studies (Bennett et al., 
2005; Bowman, 2007). Moreover, systematic reviews improve the comprehensiveness 
and objectivity of research, and contribute to the decision-making process about the 
purpose and quality of health sciences research (Bennett et al., 2005).    
Methods 
 The methodology of this study followed the framework provided by Garrard 
(2010) and included searching four electronic databases (Medline, Embase, CINAHL, 
ERIC) using variations and Boolean connectors with the terms human papillomavirus 
vaccine, health personnel (nurse, doctors, physician, school nurse, health educator), 
health services (health education, health models), and adolescents (child, schoolchildren, 
boys, girls, youth, preteen, prepubescent, pediatric, paedtric). A trained public health 
librarian, with experience in organizing and documenting searches for systematic 
literature reviews, assisted the authors in the search. In addition to the electronic 
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searches, reference lists of the included studies’ were also searched for other, potentially 
missed, citations.  
 For inclusion in this review, studies had to: (1) be published in a peer-reviewed, 
English language journal; (2) be conducted in the US; (3) be original reports of empirical 
studies; (4) focus on the HPV vaccine; (5) focus on adolescents (between 9-18 years old) 
receiving the HPV vaccine; and (6) empirically examine the knowledge, attitudes, and/or 
professional practice of the healthcare professionals or health educators regarding the 
HPV vaccine for youth. Studies were excluded if they utilized qualitative methods or 
were commentaries, editorial or personal perspective manuscripts. All articles published 
through June 2012 were retrieved (the date in which searching began). Titles, abstracts, 
and articles were reviewed and coded for eligibility by the primary author. 
 Information concerning participant characteristics, theoretical application, study 
population, and sample size were extracted from eligible studies. Each article’s 
methodological quality was examined by assessing theoretical component, study sample, 
reliability reporting, and statistical analyses.  
Findings 
Studies’ Characteristics  
 A total of 2,078 articles were initially identified. After removing duplicates (n = 
591), 1,487 articles were screened for inclusion. Twenty-eight publications met the 
inclusion criteria and were represented in the final sample, while 1,459 were excluded 
based on eligibility criteria. See Figure 3.1 for article selection and exclusion process. 
 Eighteen journals published the 28 reviewed studies included in the review. Ten  
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Figure 3.1. Flowchart of articles reviewed for inclusion in sytematic review. 
 
 
journals had a medical focus, three focused on women’s health, and two centered on 
community health.  The journals publishing the most articles included Journal of 
Adolescent Health, Journal of Pediatric and Adolescent Gynecology, and Journal of 
Lower Genital Tract Disease, each published three articles included in this review. 
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vaccine was approved). There were no articles published in 2007, but in 2008 four 
manuscripts were published. In 2009 and 2010, publications on this topic increased to 
six and seven, respectively. Furthermore, there was only one study that examined health 
educators, therefore, this review’s findings focuses on healthcare providers. Refer to 
Table 3.1 for a complete matrix of study characteristics. 
Studies’ Findings 
In the reviewed studies, five main factors were consistently targeted for study. Major 
factors included: (1) HPV and HPV vaccine knowledge, (2) attitudes, (3) perceptions, 
(4) intentions, and (5) professional practice. The subsequent findings are organized by 
these factors and various sub-factors examined in the studies. The first factor, “HPV and 
HPV vaccine knowledge,” did not have sub-factors. Under the “attitudes” factor, sub-
factors that emerged from data were: (1) communication, (2) patient's behaviors, (3) 
support for the HPV vaccine, and (4) support for a mandated HPV vaccine. For 
“perceptions,” the following sub-factors were identified: (1) barriers for providing the 
vaccine, and (2) subjective norms in administering the HPV vaccine. The “intention” 
factor was defined as “intention to recommend the HPV vaccine.” Lastly, “professional 
practice” comprised three sub-factors: (1) discussing sexuality or HPV vaccine with 
parents or patients, (2) recommending the HPV vaccine, and (3) providing the HPV 
vaccine. See Table 3.2 for all factors and sub-factors examined by the reviewed studies.  
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Table 3.1 
Matrix of the 28 Study Characteristics  
Study Pub. 
Year 
Theory Geographic Area Analysis Unit Ss Study Population Analytic Methods 
Raley et al. 2004 -- National Individual 207 OBYGYN 
Conjoint model 
(Pearson correlations) 
 
Kahn et al.  2005 
Theory of 
Planned 
Behavior 
 
National Individual 513 Pediatricians 
Linear mixed 
modeling 
Riedesel et al. 2005 
Theory of 
Planned 
Behavior 
 
National Individual 145 
Physician 
 
MANOVA, 
Multivariate linear 
regression 
Daley et al. 2006 -- National Individual 294 Pediatricians 
Multivariate analyses 
(not specified) 
 
Feemster et al.  2008 -- -- Individual 101 Pediatric Clinicians 
EFA, Multivariate 
logistic regression 
 
Ishibashi et al. 
(a) 
2008 -- National Individual 373 Pediatricians 
Chi-square test, 
Multivariate logistic 
regression 
Ishibashi et al. 
(b) 
2008 -- National Individual 373 Pediatricians 
Chi-square tests, 
Fisher exact tests, 
Multivariate logistic 
regression 
 
Jaspan et al. 2008 -- Philadelphia, PA Individual 9 OBGYN 
Descriptive 
 
Huey et al. 2009 -- Pennsylvania Organization 55 / 49 Primary Care Practices 
Descriptive 
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Table 3.1  
Continued    
Study Pub. 
Year 
Theory Geographic Area Analysis Unit Ss Study Population Analytic Methods 
        
Jensen et al. 2009 -- Dane County, WI Individual 204 
Physicians, Physician 
Assistants, and Nurse 
Practitioners 
 
Descriptive 
Kahn et al. 2009 -- Texas Individual 1122 
Family Practice, 
Pediatricians, OBGYN, 
Internal Medicine, and Other 
Chi-square, Wilcoxon 
rank-sum, t-test, 
Multivariate logistic 
regression 
 
Leddy et al. 2009 -- 
National and 
Indiana, Kentucky, 
Ohio, Michigan, 
and Ontrario, 
Canada 
 
Individual 1342 OBGYN and Other Chi-square, ANOVA 
Pearce et al. 2009 -- Chattanooga, TN Individual 95 
Pediatric and Family 
Physicians 
 
Descriptive 
Tariq et al. 2009 -- Arkansas Individual 300 
Family physicians, Internal 
medicine physicians, 
Pediatricians and OBGYNs 
 
Descriptive, Chi-
square, Cramer's V 
Askelson et al. 2010 
Theory of 
Planned 
Behavior 
Iowa Individual 207 
Family Practice Physicians, 
General Practice Physicians, 
and Pediatricians 
 
t-test, Chi-square, 
SEM 
Barnack et al. 2010 -- National Individual 100 
General Practice, Family 
Practice, Pediatricians, 
OBGYNs, and Other 
Linear regressions, 
Backward step-wise, 
Multiple regression 
analysis 
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Table 3.1         
Continued   
Study Pub. 
Year 
Theory Geographic Area Analysis Unit Ss Study Population Analytic Methods 
Daley et al.  2010 -- National Individual 680 
Family Practice, and 
Pediatricians 
 
Multivariate logistic 
regression 
Ko et al. 2010 -- -- Individual 424 
Pediatricians, OBGYNs, and 
Internists 
 
Multivariate logistic 
regression 
McCave  2010 
Theory of 
Planned 
Behavior 
New Mexico, 
North Carolina, 
Texas and 
Louisiana 
 
Individual 227 
Pediatricians, OBGYNs, 
Physicians, Physicians 
Assistant, Nurse Practitioner 
t-tests, Multiple 
regression analyses 
Schnatz et al. 2010 -- Connecticut Individual 345 Pediatricians 
Descriptive, Spearman 
rho 
 
Weiss et al. 2010 -- National Individual 1094 
Family Practice and 
Pediatricians 
Chi squared, t-tests, 
McNemar's tests 
 
Bynum et al. 2011 -- National Individual 1013 
Family Practice, 
Pediatricians, and OBGYNs 
Descriptive, Chi-
square tests 
 
Reiter et al. 2011 -- North Carolina Individual 574 Nurses and Health Educators 
Mixed regression 
models 
 
Roberto et al. 2011 
Theory of 
Reasoned 
Action/Theory 
of Planned 
Behavior 
 
A Midwest state Individual 406 Pediatricians 
t-test, Stepwise 
regression 
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Table 3.1        
Continued    
Study Pub. 
Year 
Theory Geographic Area Analysis Unit Ss Study Population Analytic Methods 
Vadaparampil 
et al. 
2011 
Competing 
Demands 
Model 
National Individual 1013 
Family Practice, 
Pediatricians, OBGYNs 
Pearson chi-square, 
Fisher's Exact test, 
Simple logistic 
regression, 
Multivariate logistic 
regression 
 
Young et al.  2011 
Theory of 
Planned 
Behavior and 
Health Belief 
Model 
Virginia Individual 385 Family Practice and OBGYN -- 
Krieger et al. 2012 
Risk 
Perception 
Attitude 
Framework 
 
Kentucky and West 
Virginia 
Individual 334 Pediatricians t-tests, CFA 
Saraiya et al. 2012 -- -- Individual 1500 
Primary Care, Pediatricians, 
and OBGYNs 
Logistic regression, 
Chi-square 
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Table 3.2 
Percentage of the 28 Study's Topics 
Topic n % 
Knowledge   
 HPV 9 32.1 
 HPV vaccine 5 17.8 
Attitudes   
 Support 8 28.6 
 Communication 8 28.6 
 Patient's sexual behavior 7 25.0 
 Mandated HPV vaccine 4 14.3 
 HPV vaccine concerns 4 14.3 
 Administering HPV vaccine 3 10.7 
 HPV vaccine importance 3 10.7 
 HPV vaccine delivery success 2 7.1 
Perceptions   
 Barriers in providing HPV vaccine 12 42.9 
 Subjective norms regarding HPV 
vaccine 
6 21.4 
 Patients' sexual behavior 3 10.7 
 Behavioral control administering 3 10.7 
 HPV vaccine 1 3.6 
Intention   
 HPV vaccine recommendation 11 39.2 
 Vaccinating against HPV  3 10.7 
 Communication 1 3.6 
 Adhering to guidelines/professional 
recommendations 
1 3.6 
Professional Practice   
 Providing HPV vaccine 10 35.7 
 Discussing sexuality/HPV vaccine 7 25.0 
 Recommending HPV vaccine 7 25.0 
 Offer HPV vaccine 4 14.3 
 Seeking HPV vaccine information 4 14.3 
 Barriers in providing HPV vaccine 2 7.1 
 Discussing HPV 1 3.6 
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Knowledge of HPV & HPV vaccine. Knowledge of HPV was assessed in nine studies 
(Daley et al., 2006; Daley et al., 2010; Kahn et al., 2005; Kahn et al., 2009; Pearce et al., 
2009; Reiter et al., 2011; Riedesel et al., 2005; Schnatz, Humphrey, & O'Sullivan, 2010; 
Weiss et al., 2010). In these studies, healthcare providers appeared to have some 
knowledge of the virus, with correct responses for items assessing HPV knowledge 
ranging from 22% to 95%—of HPV. Studies reported between 45% to 95% of 
healthcare providers knew HPV can result in cervical cancer (Daley et al., 2006; Daley 
et al., 2010; Kahn et al., 2005; Kahn et al., 2009; Reiter et al., 2011; Riedesel et al., 
2005).   
 Knowledge of the HPV vaccine was assessed in five studies (Daley et al., 2006; 
Daley et al., 2010; Leddy et al., 2009; Reiter et al., 2011; Saraiya et al., 2012). One study 
revealed 98% of physicians reported the HPV vaccine was effective at preventing 
cervical cancer, but less than 53% reported the vaccine prevents anal cancer (Saraiya et 
al., 2012). There appeared to be less variation in HPV vaccine knowledge scores ranging 
from 77% to 91% (Daley et al., 2010).  
Attitudes. Six studies revealed healthcare providers reported feeling comfortable 
discussing sexuality issues, including the HPV vaccine, with adolescents or parents 
(Daley et al., 2006; Daley et al., 2010; Kahn et al., 2005; McCave, 2010; Pearce et al., 
2009; Riedesel et al., 2005). No healthcare provider believed that discussing the HPV 
vaccine was outside the scope of his/her practice (Pearce et al., 2009). One report found 
no statistically significant relationship between healthcare provider's gender and comfort 
in discussing sexuality (Ko et al., 2010). 
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Seven articles reported very few healthcare providers (ranging from 0% to 35%) 
believed the HPV vaccine would promote sexual behavior among adolescents (Daley et 
al., 2006; Daley et al., 2010; Ishibashi, Koopmans, Curlin, Alexander, & Ross, 2008b; 
Ko et al., 2010; Pearce et al., 2009; Saraiya et al., 2012; Tariq et al., 2009; Young et al., 
2011). Male healthcare providers, as well as 26% to 35% of minority healthcare 
providers, however, believed the vaccine might dissuade patients from receiving routine 
cervical cancer screening (Ko et al., 2010; Young et al., 2011). Two reports cited 
between 20% and 60.5% of healthcare providers claimed parents believe the vaccine 
would encourage child’s risky sexual behavior (Daley et al., 2006; Tariq et al., 2009).  
 Numerous studies assessed support for the HPV vaccine. The studies revealed 
between 61% to 99% of healthcare providers supported the HPV vaccine (Ishibashi, 
Koopmans, Curlin, Alexander, & Ross, 2008a; Ishibashi et al., 2008b; Pearce et al., 
2009; Tariq et al., 2009). Two other studies found supportive attitudes from healthcare 
providers regarding the HPV vaccine, believing the vaccine as beneficial, a good idea, 
and having a positive impact on women’s lives (Askelson et al., 2010; McCave, 2010). 
Another study documented that over 90% of healthcare staff would vaccinate their 
daughters (Reiter et al., 2011). However, only 36.7% to 38.6% of healthcare providers 
expressed having a positive experience with the HPV vaccine (e.g., daughter receiving 
the vaccination; McCave, 2010). 
Providers were more likely to support the HPV vaccine if it were used to prevent 
cervical cancer exclusively or cervical cancer and genital warts; they were less likely to 
support the vaccine if it were used to solely prevent genital warts (Raley et al., 2004). 
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Four articles also discussed support for a mandated HPV vaccine. Support for a 
mandated HPV vaccine fell between 34% and 59% across reviewed studies (Kahn et al., 
2009; Leddy et al., 2009; Tariq et al., 2009; Young et al., 2011).  
 Perceptions. In the reviewed literature, researchers conceptualized and assessed 
perceptions of healthcare providers as: (1) barriers for providing the vaccine and (2) 
subjective norms regarding the HPV vaccine. The main barrier, vaccine costfor either 
the provider or the parents/patientswas identified in 12 of the 28 reports (Askelson et 
al., 2010; Barnack et al., 2010; Daley et al., 2006; Daley et al., 2010; Jaspan et al., 2008; 
Kahn et al., 2005; Ko et al., 2010; Leddy et al., 2009; McCave, 2010; Riedesel et al., 
2005; Tariq et al., 2009; Young et al., 2011). Other perceived barriers for healthcare 
providers administering the HPV vaccine included patients or parents refusing because 
of concerns about vaccine safety (Daley et al., 2010; Jaspan et al., 2008; Kahn et al., 
2005; Ko et al., 2010; Riedesel et al., 2005), and parents’ concerns the HPV vaccine will 
lead to increased risky sexual behaviors (Daley et al., 2010; Kahn et al., 2005; Ko et al., 
2010; Riedesel et al., 2005).  
 Six reports measured subjective norms regarding the HPV vaccine. The 
likelihood of healthcare providers following vaccine recommendations from the 
American Academy of Pediatrics/Redbook, CDC, and ACIP was above 90% (Kahn et 
al., 2005; Riedesel et al., 2005). Other studies included in this review consistently found 
that professional organizations providing information about, and recommending 
adolescents receive the HPV vaccine impacts the healthcare providers’ HPV vaccine 
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recommendation and administering behaviors (Askelson et al., 2010; Jensen et al., 2009; 
Kahn et al., 2009; Raley et al., 2004).   
 Intention. Intention was operationalized in the reviewed studies, mainly, as 
recommending the HPV vaccine. Out of the ten studies reporting on intention, three 
found more than 80% of healthcare providers were likely or willing to recommend the 
HPV vaccine (Barnack et al., 2010; Feemster et al., 2008; Jensen et al., 2009). Yet, only 
42% were extremely likely to recommend the HPV vaccine to 11 to 12 year old males 
and 26% were somewhat likely (Kahn et al., 2009). Factors found to be associated with 
intention to recommend the HPV vaccine included the patient being female (Daley et al., 
2006; Kahn et al., 2005; Riedesel et al., 2005), the patient being older (Daley et al., 
2006; Kahn et al., 2005; Kahn et al., 2009; Riedesel et al., 2005), healthcare providers’ 
HPV knowledge (Kahn et al., 2005; Kahn et al., 2009; Riedesel et al., 2005), providers’ 
gender (female; Daley et al., 2006; Kahn et al., 2009; Riedesel et al., 2005), healthcare 
providers’ response-efficacy (Krieger et al., 2012) and recommendation by professional 
organizations (Askelson et al., 2010; Kahn et al., 2005; Riedesel et al., 2005). 
Conversely, some studies found that HPV knowledge, anticipating parents’ concerns 
relating to sexuality (Feemster et al., 2008), providers’ gender (Feemster et al., 2008; 
Roberto et al., 2011), and HPV vaccine attitudes (Askelson et al., 2010) were not 
associated with recommendation intentions.  
 Professional Practice. Over 70% of healthcare providers discussed sexuality 
with adolescents during an appointment (Kahn et al., 2005; Riedesel et al., 2005; Weiss 
et al., 2010), while over 90% of healthcare providers claimed they were educating 
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parents about the HPV vaccine (McCave, 2010; Schnatz et al., 2010). However, when 
asked specifically about having conversations with the patients themselves, only 18% of 
providers reported doing so (Pearce et al., 2009). The main vaccine benefits healthcare 
providers reported discussing with patients was prevention of cervical cancer and genital 
warts (Daley et al., 2010; Jensen et al., 2009). To educate patients about the HPV 
vaccine, 53% of providers claimed using brochures and verbal messages (Tariq et al., 
2009). 
 Recommending the HPV vaccine was examined in seven reports. Patient’s age 
was an important factor in recommending the HPV vaccine, with middle to late 
adolescents (13-18 years) receiving the highest percentage of recommendations 
(between 39% to 98% of healthcare providers said they recommended), followed by 
adolescents aged 11-12 years (49% to 70% recommended) and adolescents aged 10 
years and younger (6% to 34% of providers claimed making recommendations to this 
age group; Daley et al., 2010; Huey et al., 2009; Kahn et al., 2009; Vadaparampil et al., 
2011; Weiss et al., 2010; Young et al., 2011).  
Factors related to not recommending the HPV vaccine included concerns about 
the vaccine’s safety or efficacy, patients’ future screening compliance, inadequate 
reimbursement, lack of educational materials (Young et al., 2011), belief it is essential to 
discuss sexuality before recommending the HPV vaccine, and reports more parents 
refuse the vaccine for younger patients compared to older patients (Daley et al., 2010). 
One study found that intention to recommend the HPV vaccine was not associated with 
HPV vaccine recommendation behavior (Krieger et al., 2012). 
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 Ten studies reported on the actual HPV vaccination delivery by healthcare 
providers. HPV vaccination delivery varied, with 70% to 98% making the vaccine 
available in their practices (Daley et al., 2010; Ko et al., 2010; Leddy et al., 2009; Tariq 
et al., 2009; Young et al., 2011) and patients’ vaccination rates ranging between 6% to 
67% (Jaspan et al., 2008; Schnatz et al., 2010). Older adolescents were more frequently 
vaccinated than younger adolescents (Huey et al., 2009; Ko et al., 2010; McCave, 2010; 
Tariq et al., 2009). However, one study reported the average age range for receiving the 
vaccine was 19-22 years old (Young et al., 2011) and another study documented that 
10.9 years (SD = 1.7) was the mean age for vaccinating patients (Askelson et al., 2010). 
When looking at predictors of vaccinating patients, fewer barriers and being a 
pediatrician were associated with higher vaccination rates (McCave, 2010).  See Table 
3.3 for a summary of the findings.  
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Table 3.3 
Summary of Findings for the 28 Studies  
Study Knowledge Attitudes Perceptions Intention Professional Practice 
Raley et al. -- Participants supported an 
HPV vaccine that prevented 
cervical cancer or cervical 
cancer AND genital warts 
versus an HPV vaccine 
preventing genital warts 
 
ACOG approval of the 
HPV vaccine was 
perceived as important 
-- -- 
Kahn et al. Mean HPV 
knowledge score = 
1.86 (SD = 1.29) of 
5.0 
84.4% of participants were 
comfortable discussing 
adolescent sexuality 
Perceived barriers to 
vaccinating against HPV: 
parental concern about 
safety, parental concern 
about vaccinating against 
STI, parental reluctance to 
discuss sexuality, parental 
concern about encouraged 
sexual activity, 
administration costs 
 
Over 90% of participants 
would follow the vaccine 
recommendation from: 
American Academy of 
Pediatrics/Redbook, 
CDC, Advisory 
Committee on 
Immunization Practices 
Factors associated with 
intention to recommend 
HPV vaccine: patient 
gender, patient age, 
vaccine type, 
interaction of patient 
age and gender, 
interaction of patient 
age and vaccine type, 
interaction of patient 
gender and vaccine type 
 
Participants more likely 
to recommend a 
cervical cancer/genital 
wart vaccine to girls 
than cervical cancer 
vaccine 
 
Participants more likely 
to recommend a 
cervical cancer/genital 
wart vaccine to girls 
than boys and cervical 
cancer vaccine to boys 
 
Over 80% of participants 
discuss sexuality with 
patients almost all of the 
time/most of the time 
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Table 3.3 
Continued 
Study Knowledge Attitudes Perceptions Intention Professional Practice 
    Participants more likely 
to recommend vaccine 
to 17 year old than 14 
year old or a 11 year 
old and more likely to 
recommend to a 14 year 
old than 11 year old 
 
Variable associated 
with intention to 
recommend cervical 
cancer vaccine: 
provider age and gender 
(male), 10-15 year old 
patients seen for routine 
health visits, perceived 
% of sexually active 15 
year old patients, likely 
to follow 
recommendation  from 
influential person or 
organization (normative 
beliefs) 
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Table 3.3      
Continued 
Study Knowledge Attitudes Perceptions Intention Professional Practice 
    Variable associated 
with intention to 
recommend cervical 
cancer/genital warts 
vaccine:10-15 year old 
patients seen per week, 
HPV knowledge, 
perceived % of sexually 
active 15 year old 
patients, likely to 
follow recommendation  
from influential person 
or organization 
(normative beliefs), 
fewer perceived barriers 
to recommending 
vaccine 
 
  
Riedesel et al. Mean HPV 
knowledge score = 
2.9 (SD = 1.1) of 5.0 
90.9% of participants were 
comfortable addressing 
adolescent sexuality 
Perceived barriers to 
vaccinating against HPV: 
parental concern about 
safety, parental concern 
about vaccinating against 
STI, parental reluctance to 
discuss sexuality, parental 
concern about encouraged 
sexual activity, cost to 
provider's practice, 
parental belief child is 
singled out for STI 
vaccine, provider 
reluctance to discuss 
sexuality 
Providers were more 
likely to intend to 
recommend the HPV 
vaccine to females than 
males, older 
adolescents than 
younger adolescents, 
and a vaccine 
protecting against 
cervical cancer and 
genital warts compared 
to a vaccine protecting 
only against cervical 
cancer 
 
Over 70% of participants 
discuss sexuality with 
patients almost all of the 
time/most of the time 
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Table 3.3      
Continued 
Study Knowledge Attitudes Perceptions Intention Professional Practice 
   Over 90% of participants 
would follow the vaccine 
recommendation from: 
American Academy of 
Family Physicians, 
American Academy of 
Pediatrics/Redbook, 
CDC, Advisory 
Committee on 
Immunization Practices 
Variables associated 
with intention to 
recommend cervical 
cancer vaccine: 
provider gender 
(female), stronger 
normative beliefs 
(influential individuals 
or organizations) 
 
Variables associated 
with intention to 
recommend cervical 
cancer and genital wart 
vaccine: better HPV 
knowledge, stronger 
normative beliefs 
(influential individuals 
or organizations), fewer 
perceived barriers to 
vaccination and control 
to vaccinate 
 
 
Daley et al. Participants’ HPV 
knowledge varied 
according to sub-
topic 
 
43% of participants 
unaware of highly 
effective HPV 
vaccines under 
development 
88% and 93% of participants 
were comfortable discussing 
sexuality with female and 
male patients, respectively 
 
Perceived barriers to 
vaccinating against HPV: 
lack of reimbursement, 
up-front practice costs of 
vaccine, parental refusal 
Participants more likely 
to recommend vaccine 
to older adolescents 
than younger 
adolescents and females 
compared to males 
 
-- 
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Table 3.3      
Continued 
Study Knowledge Attitudes Perceptions Intention Professional Practice 
  60.5% believed parents might 
be concerned the HPV 
vaccine could increase 
adolescents' risky sexual 
behaviors, 10.7% of 
participants had this same 
concern 
 
 Participants unlikely to 
recommend vaccine to 
any age groups were 
more likely to be males 
and feel uncomfortable 
discussing sexuality 
with female patients 
 
Variables associated 
with being likely to 
vaccinate 10-12 year 
old females: knowledge 
about HPV vaccine 
being developed, 
believing that other 
adolescent vaccine 
would facilitate 
introducing HPV 
vaccine 
 
Variables negatively  
associated with being 
likely to vaccinate 10-
12 year old females: 
believing it necessary to 
discuss sexuality before 
vaccination, parents' 
concern about STI 
vaccine for young 
adolescents, parental 
refusal as a barrier 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 47 
 
Table 3.3      
Continued   
Study Knowledge Attitudes Perceptions Intention Professional Practice 
    Female providers were 
more likely than males 
providers to foresee 
themselves vaccinating 
male patients 
 
 
Feemster et al. -- -- -- 96%  of participants 
reported being 
extremely likely or 
somewhat likely to 
recommend the vaccine 
to 11- to 12- old 
females 
 
Variables associated 
with likelihood of 
intention to vaccinate 
11-12 year old girls: 
being an early adopter 
of new technologies, 
anticipating parental 
concerns regarding 
vaccine efficacy and  
safety 
 
-- 
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Table 3.3      
Continued   
Study Knowledge Attitudes Perceptions Intention Professional Practice 
    Variables not associated 
with intention to 
vaccinate: provider's 
gender, comfort level of 
discussing sexuality 
with 11-12 year old 
patients, HPV 
knowledge, anticipating 
parental concerns about 
sexuality, provider 
concerns about 
sexuality, anticipate 
prevention benefits of 
HPV vaccine, 
anticipant mandates 
improving vaccine 
delivery success, 
increased perception of 
patient risk 
 
 
Ishibashi et al. 
(a) 
-- 99% of paediatricians support 
the HPV vaccine 
-- -- 88% of participants would 
give HPV vaccine to all 
eligible patients 
 
Those who would not provide 
HPV vaccine were more 
likely to: be paediatricians, 
have high intrinsic religiosity, 
be conservative, be late 
adopters of new 
drugs/vaccines, be less likely 
to encourage vaccinating 
daughter or close friend's 
daughter                
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Table 3.3      
Continued   
Study Knowledge Attitudes Perceptions Intention Professional Practice 
     There was no predictive 
demographic variable for not 
providing the vaccine 
 
Ishibashi et al. 
(b) 
-- Compared to the general 
public, pediatricians were 
less likely to believe the HPV 
vaccine would encourage 
sexual activity and more 
likely to support the HPV 
vaccine without parental 
permission 
 
No variable was a predictor 
for believing routine Pap 
smears were better method of 
preventing cervical cancer or 
that the HPV vaccine would 
encourage sexual activity 
 
Gender was not a predictor 
for any item: parental 
permission, vaccine 
encourages sex, or abstinence 
program was better 
prevention method 
 
-- -- -- 
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Table 3.3      
Continued   
Study Knowledge Attitudes Perceptions Intention Professional Practice 
Jaspan et al. -- -- 33% of participants 
reported barriers: patients 
concerned about safety, 
costs 
-- HPV vaccine was provided to 
28.2% of female patients 
 
HPV vaccination rates varied 
between 6% to 55.8% 
 
Huey et al. -- -- -- -- 90% of practices reported 
patients requesting vaccine 
for themselves or their 
daughters 
 
94% of practices reported 
recommending the vaccine to 
patients 
 
22% of practices reported 
vaccinating only those aged 
18 to 26 
 
39% of practices reported 
vaccinating only those 
younger than 18 years 
 
24% of practices reported 
vaccinating both age groups 
(younger than 18 and 18 to 
26) 
 
15% of practices did not 
report vaccinating specific 
age groups 
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Table 3.3      
Continued   
Study Knowledge Attitudes Perceptions Intention Professional Practice 
Jensen et al. -- -- Health professional 
associations and FDA 
recommendations 
influenced participants' 
decisions to recommend 
the HPV vaccine 
 
Health benefits from 
vaccination 
practitioners plan to 
discuss with patients 
were the decreased risk: 
of cervical cancer, HPV 
infection, genital warts, 
any STI 
 
95% of participants 
reported willingness to 
recommend HPV 
vaccine to adolescent 
patients 
 
Participants reporting 
unwillingness to 
recommend HPV 
vaccine cited reasons as 
lack of fit with practice 
and taking the "wait 
and see" approach 
 
67% of participants 
were planning to 
recommend the vaccine 
to female patients only 
 
14% of participants 
were planning on 
recommending to 
females and males 
 
 
Participants reported feeling 
comfortable vaccinating 
patients older than 10 years 
and uncomfortable 
vaccinating  patients younger 
10 years 
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Table 3.3      
Continued   
Study Knowledge Attitudes Perceptions Intention Professional Practice 
    13% of participants 
were planning on 
recommending to a 
majority of female and 
some male patients 
 
 
Kahn et al. HPV knowledge was 
fair ranging from 
22%-75% 
 
44% of participants 
reported having more 
HPV information 
would be helpful 
41.7% of participants agreed 
the HPV vaccine should be 
mandated for 11-12 year old 
females in Texas 
 
Predictors of agreement with 
HPV vaccine mandate: 
seeing more patients covered 
by Medicaid and academic 
versus nonacademic patient 
care 
Most valued sources to 
HPV vaccine information: 
professional 
organizations, academic 
article and journals, 
professional conferences 
or meetings 
Participants more likely 
to recommend HPV 
vaccine to boys 
between 13-17 years, 
followed by 18-26 
years, 11-12years, and 
9-10 years 
 
Higher knowledge 
about HPV, female 
provider, belief vaccine 
should be mandated for 
11-12 year old girls in 
Texas were 
independently 
associated with 
intention to recommend 
HPV vaccine to 11-12 
year old boy 
81% of participants reported 
having recommended an 
HPV vaccine to patients of 
any age 
 
Participants reported 
recommending vaccination to 
females 13-17 years the most, 
followed by 18-26 year old, 
11-12 year olds, and then 9-
10 year olds 
 
Variables predicting 
recommending HPV vaccine 
to 11-12 year old females 
included: higher HPV 
knowledge about HPV, 
perceiving professional 
organizations and 
conferences as valuable 
sources of HPV vaccine, 
belief for mandated HPV 
vaccine for school 
enrollment, experience of 
higher number of barriers to 
vaccinate 
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Table 3.3      
Continued   
Study Knowledge Attitudes Perceptions Intention Professional Practice 
Leddy et al. 22.9% and 29.4% of 
participants answered 
all items about the 
HPV vaccine 
correctly 
In District V, 39.8% of 
participants agreed with a 
mandated HPV vaccine 
 
34.4% of CARN participants 
agreed with a mandated HPV 
vaccine 
 
The main reason to not 
mandate the HPV vaccine 
was financial cost to patient 
 
District V and CARN 
participants named the 
following as barriers to 
vaccinating against HPV: 
patient refuses vaccine 
based on cost, patient 
does not feel at risk for 
HPV 
-- District V: participants with 
higher HPV vaccine 
knowledge were more likely 
to give vaccine in office 
 
District V: of the participant 
who give vaccines, 87.6% 
administer the HPV vaccine 
 
CARN: no relationship 
between participants’ HPV 
vaccine knowledge and 
providing vaccine in office 
 
CARN: of the participant 
who give vaccines, 91.0% 
administer the HPV vaccine 
 
Pearce et al. All participants 
reported some HPV 
knowledge 
85% and 78% of participants 
were comfortable counseling 
parents about STIs and 
counseling/providing the 
HPV vaccine, respectively 
 
No participant felt the HPV 
vaccine encouraged sexual 
activity 
 
No participant felt that 
providing the vaccine was 
outside scope of practice 
 
 
-- -- 18% of participants who 
indicated feeling comfortable 
counseling and providing the 
HPV vaccine have already 
discussed the vaccine with 
some patients 
 
 
 
 
 
 
 
 
 
 
 54 
 
Table 3.3      
Continued   
Study Knowledge Attitudes Perceptions Intention Professional Practice 
  63% of participants believed 
males and females should 
receive the HPV vaccine 
 
   
Tariq et al. -- Less than 35% of participants  
agreed with a mandated HPV 
vaccine 
 
80% of participants did not 
think the vaccine encourages 
sexual activity 
 
20% of participants thought 
parents believed the vaccine 
did encourage sexual activity 
 
61% of participants felt 
males should receive the 
vaccine 
Perceived barriers to 
vaccinating against HPV: 
cost of administering the 
vaccine, parents think the 
vaccine costs too much, 
compliance of three series 
shot 
 
 
-- 53% and 35% of participants 
use both brochures and verbal 
messages, and only verbal 
messages, respectively, to 
provide HPV vaccine 
education 
 
92% of participants felt 
comfortable providing HPV 
vaccine education 
 
Participants not providing the 
vaccine were more likely to 
believe the three shot series 
limits compliance for 
completion 
 
Participants reported 
vaccinating females 15-19 
years the most, followed by 
9-14 year old, and then 20-26 
year olds 
 
73% of participants provide 
vaccine in office 
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Table 3.3      
Continued   
Study Knowledge Attitudes Perceptions Intention Professional Practice 
Askelson et al. -- Participants overall had 
positive attitudes towards the 
HPV vaccine 
Perceived barriers to 
vaccinating against HPV: 
cost, parents 
 
Most participants 
perceived that people 
important to them think 
they should vaccinate 
based on 
recommendation, that 
they were expected to 
vaccinated based on 
recommendations, and 
professional whose 
opinions they valued 
think they should 
vaccinated based on 
recommendations 
Majority of participants 
intended to adhere to 
ACIP's 
recommendations 
 
86.5% of participants 
reported they intend to 
vaccinate female 
patients 
 
Good model fit for 
attitudes to vaccinate, 
subjective norms, 
perceived behavioral 
control predicting 
intention to vaccinate 
 
Subjective norms and 
perceived behavioral 
control were associated 
with intention to 
vaccinate 
 
Attitudes to vaccinate 
were not significantly 
related to intention to 
vaccinate 
 
Mean age for giving HPV 
vaccine to patients was 10.93 
years 
Barnack et al. -- -- 63% of participants 
reported the costs of the 
HPV vaccine as a barrier 
to vaccination 
82% of participants 
plan to recommend 
parents to vaccinate 
child against HPV 
 
-- 
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Table 3.3      
Continued   
Study Knowledge Attitudes Perceptions Intention Professional Practice 
    Physician specialty was 
associated with intent to 
recommend the vaccine 
(pediatricians had 
highest mean intention 
score compared to 
general practitioner, 
and OB/GYN) 
 
Physician specialty and 
intent to vaccinate own 
child were significant 
predictors for intention 
to recommend vaccine 
 
 
Daley et al. HPV knowledge 
varied and ranged 
from 43%-95% 
 
HPV vaccine 
knowledge had less 
variation with rages 
between 77%-91% 
Large majority of participants 
were comfortable discussing 
sexuality with female patients 
 
Less than 10% of participants 
believed the vaccine would 
encourage risky sexual 
activity 
Perceived barriers to 
vaccinating against HPV: 
insurance companies not 
covering HPV vaccine, 
lack of reimbursement of 
HPV vaccine, up-front 
practice costs, parent 
concerned about safety, 
parents concerned about 
increased risky sexual 
behavior 
-- Participants reported 
discussing cervical cancer 
prevention, prevention of 
genital warts in the patients, 
and prevention of genital 
warts in partner 
 
More participants strongly 
recommended the HPV 
vaccine for older age groups: 
16-18 years, followed by 19-
26 years, 13-15 years, 11-12 
years, and then 9-10 years 
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Table 3.3      
Continued   
Study Knowledge Attitudes Perceptions Intention Professional Practice 
     Variables associated with not 
recommending the HPV 
vaccine to females 11-21 
years included: believing it is 
necessary to discuss sexuality 
before recommending HPV 
vaccine, reporting the time it 
takes to discuss HPV vaccine, 
reporting more parental 
refusals for younger patients 
compared to older patients 
 
98% and 88% of participants 
reported the vaccine was 
provided in their office 
 
Ko et al. -- No statistical significance 
between providers' gender 
and comfort in discussing 
sexuality or belief that the 
vaccine would decrease 
condom use/increase risky 
sexual activity 
 
Male participants were more 
likely to believe the vaccine 
would decrease 
gynecological examinations 
and Pap smears 
Perceived barriers to 
vaccinating against HPV: 
none, reimbursement 
(costs) concerns, patient 
or parent concerns about 
side effects (safety) and 
increasing risky sexual 
behavior, patient or parent 
not asking for vaccine 
 
No difference in 
providers' gender in 
reporting barriers to 
vaccinating against HPV 
-- 90.9% of participants  
vaccinating females aged 19-
26 years 
 
60.5% of participants  
vaccinating females aged 14-
18 years 
 
35.7% of participants  
vaccinating females aged 9-
13 years 
 
10.0% of participants 
vaccinating females older 
than 26 years 
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Table 3.3      
Continued   
Study Knowledge Attitudes Perceptions Intention Professional Practice 
     80% of participants reported 
the vaccine was provided in 
their office 
 
Male providers' less likely to 
provide vaccine than female 
providers 
 
McCave -- Over 69% of participants 
were comfortable discussing 
the vaccine with parents 
 
Over 84% of participants 
believed the vaccine will 
have positive impact in 
women's lives 
 
Between 36.7% and 38.6% of 
participants reported having a 
positive experience with 
HPV vaccine (e.g., daughter 
vaccinated) 
 
Perceived barriers to 
vaccinating against HPV: 
concerns about costs for 
patient and self, 
professional concerns 
about HPV vaccine 
safety, concerns about 
HPV policy initiative, 
limited knowledge on 
HPV vaccine 
 
-- Majority of  participants 
reported counseling parent of 
HPV vaccine 
 
The mean HPV vaccination 
rate for females 13–17 years 
was greater than mean HPV 
vaccination rate for females 
9–12 years 
 
Fewer barriers was associated 
with providers’ HPV 
vaccination rates of females 
9-12 years 
 
Fewer barriers and being a 
pediatrician was associated 
with providers’ HPV 
vaccination rates of females 
13-17 years 
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Table 3.3      
Continued   
Study Knowledge Attitudes Perceptions Intention Professional Practice 
Schnatz et al. 90.7% of participants 
reported being "very 
knowledgeable" or 
"moderately 
knowledgeable" 
about HPV 
-- -- Statistically significant 
correlation between 
providers' HPV 
knowledge and 
willingness to discuss 
STIs 
94%  of participants reported 
discussion of HPV vaccine 
when discussing STIs 
 
No association between self-
reported knowledge and 
providing HPV vaccine 
 
Participants reported 67% of 
parents allowed daughters to 
receive HPV vaccine 
 
Weiss et al. Knowledge about 
HPV in male patients 
ranged from 19.5%-
79% 
-- -- -- More participants 
recommending the HPV 
vaccine to males and females 
13-18 years old, followed by 
19-26 year olds, 11-12 years 
old, and 9-10 year olds 
 
Physicians preferred to 
recommend the HPV vaccine 
to females 
 
Bynum et al. -- -- -- -- **Reported HPV vaccine 
information seeking behavior 
(not a major theme) 
 
Reiter et al. Participants reported 
an increase in self-
rated HPV 
knowledge after the 
intervention 
 
Healthcare staff  participants 
believed HPV education for 
the community was valuable 
 
 
-- -- -- 
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Table 3.3      
Continued   
Study Knowledge Attitudes Perceptions Intention Professional Practice 
 After the 
intervention, there 
was some increase in 
HPV and HPV 
vaccine knowledge 
After intervention, 91% of 
participants would vaccinate 
their own daughter against 
HPV 
 
After the intervention, an 
increased number of school 
staff participants believed 
HPV and HPV vaccine 
education was valuable for 
school personnel, middle 
school was appropriate for 
such education, and 
comfortable with their HPV 
knowledge if approached by 
student 
 
   
Roberto et al. -- There were no differences on 
participants' gender regarding 
attitudes regarding 
encouragement of parents to 
have daughters vaccinated 
against HPV 
There were no differences 
on participants' gender 
regarding subjective 
norms and perceived 
behavioral control 
regarding encouragement 
of parents to have 
daughters vaccinated 
against HPV 
 
There were no 
differences on 
participants' gender 
regarding behavioral 
intentions regarding 
encouragement of 
parents to have 
daughters vaccinated 
against HPV 
There were no differences on 
participants' gender regarding 
the behavior of encouraging 
parents to get daughters 
vaccinated against HPV 
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Table 3.3      
Continued   
Study Knowledge Attitudes Perceptions Intention Professional Practice 
Vadaparampil 
et al. 
-- -- -- -- 34.6% , 52.7%, and 50.2% of 
participants reported always 
recommending the HPV 
vaccine to early, middle, and 
late adolescents/ 
young adults, respectively 
 
Variables predicting the 
recommendation of the HPV 
vaccine included: providers' 
specialty (specifically 
pediatricians), being a 
Hispanic or Latino physician, 
reporting a less barriers to 
vaccination 
 
Young et al. -- 26% and 35% of minority 
participants were concerned 
the HPV vaccine would 
increase unprotected sexual 
intercourse and decrease 
compliance with cervical 
cancer screening, 
respectively 
 
Over 90% of participants 
believed the HPV vaccine 
was safe, effective, but would 
decrease the incidence of 
abnormal pap tests and 
cervical cancer 
 
Perceived barriers to 
vaccinating against HPV: 
reimbursement, cost to 
parents and patients, no 
vaccine no stock, not 
enough discussion time, 
lacking patients education 
materials, staff too busy 
to administer vaccine 
53% of participants 
reported willingness to 
discuss HPV vaccine 
with patients 
 
29% of participants reported 
bringing patients' attention to 
the HPV vaccine only at 
annual exam 
 
68% to 72% of providers 
actively recommend the HPV 
vaccine to all 16-26 year old 
females 
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Table 3.3      
Continued   
Study Knowledge Attitudes Perceptions Intention Professional Practice 
  59% of participants 
supported the state mandate 
for the HPV vaccine 
  Variable predicting decreased 
likelihood of recommending 
the vaccine were: physicians 
expressing safety or efficacy 
concerns, concerns about 
future compliance with 
screening, lack of educational 
materials as a perceived 
barrier, inadequate 
reimbursement 
 
70% to 73.5% of participants 
provided HPV vaccine in 
their practice 
 
19-22 years old were reported 
as most common age of 
vaccination 
 
Krieger et al. -- -- -- Mean score for 
intention to encourage 
the HPV vaccine = 6.32 
(SD = 1.29) of 7.0 
 
Healthcare provider 
response-efficacy was 
associated with 
intentions to encourage 
vaccination 
 
Mean score for having 
encouraged the HPV vaccine 
= 5.11 (1.53) of 6.0 
 
Intention to encourage the 
HPV vaccine was not 
significantly associated with 
vaccine encouragement 
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Table 3.3      
Continued   
Study Knowledge Attitudes Perceptions Intention Professional Practice 
      
     Significant mean differences 
in past HPV vaccine 
encouragement for 
participants practicing in 
Appalachia counties 
compared to non-Appalachia 
 
Non-Appalachia participants 
reported encouraging the 
HPV vaccine more than 
Appalachia participants 
 
Saraiya et al. Percent ranges for 
HPV vaccine 
preventing: cervical 
cancer (97.8%), anal 
cancer (19.2%-
52.4%), and 
oropharyngeal cancer 
(9.2%-27.6%) 
-- -- -- 98.9% of participants 
reported treating patients 
eligible for HPV vaccine 
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Methodological Quality. Each of the studies methodological quality was 
assessed to understand the methods utilized to collect and analyze the data. The use of 
theory, study sample, data validity and reliability and analytic methods were examined. 
 Use of theory to guide inquiry. Of the 28 articles reviewed, 29% (n = 8) 
explicitly cited a theoretical framework to guide the research. The most frequently used 
theory was the Theory of Reasoned Action/Planned Behavior (Askelson et al., 2010; 
Kahn et al., 2005; McCave, 2010; Riedesel et al., 2005; Roberto et al., 2011; Young et 
al., 2011). Other frameworks utilized were the Competing Demand Model 
(Vadaparampil et al., 2011), Health Belief Model (Young et al., 2011), and Risk 
Perception Attitude (RPA) framework (Krieger et al., 2012).  One study reported using 
multiple theories (Theory of Planned Behavior and Health Belief Model; Young et al., 
2011). 
 Study sample. More than half of the articles (n = 16, 57%) reported a sample size 
larger than 300 respondents. Of the 28 manuscripts, 14 (50%) reported local or state-
level data. Two reports did not state the data collection location, and 12 (43%) 
manuscripts conducted research on a national sample. Only one study assessed health 
educators, with nurses. 
 Data validity and reliability. We assessed whether each study reported on the 
reliability/validity of its data. Among the 28 articles reviewed, 16 (57%) explained how 
validity was assessed for the instrument. Nine studies (32%) described having the 
instrument pilot-tested or reviewed by experts and eight (29%) reported utilizing items 
created from other instruments or previous studies.  Less than one-third of the reviewed 
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studies (n = 8, 29%) provided evidence of the data's reliability (e.g., by reporting their 
level of internal consistency, through Cronbach's alpha). 
 Analytic methods. In most of the reviewed studies, regression (e.g., multivariate, 
logistic, linear, step-wise; n = 13, 46%) and chi-square tests (n = 8, 29%) were 
conducted. The third most commonly employed analysis was t-tests (n= 6, 21%). Less-
frequently used statistical analyses included analysis of variance (ANOVA; Leddy et al., 
2009), multivariate analysis of variance (MANOVA; Riedesel et al., 2005), exploratory 
factor analysis (EFA; Feemster et al., 2008), confirmatory factor analysis (CFA; Krieger 
et al., 2012), and structural equation modeling (SEM; Askelson et al., 2010). 
Discussion 
 We systematically reviewed 28 studies examining healthcare providers’ 
knowledge, attitudes, and/or professional practice regarding the HPV vaccine for youth. 
However, we found these studies also assessed the perceptions and intentions regarding 
the HPV vaccine. Furthermore, this review describes these studies’ methodological 
quality, specifically the use of theory, sample size/characteristics, reporting of data’s 
reliability, and data analyses. 
 This methodological quality assessment indicated the reviewed literature suffers 
from important methodological limitations.  More specifically, in examining use of 
theory, only 29% of articles citied a theory to guide the research. With less than one-
third of the literature guided by theory, important questions remain regarding these 
studies contribution to knowledge development (Goodson, 2010).  
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About half (57%) of the articles reported some type of validity assessment and an 
even smaller number of articles (29%) reported on the data’s validity and reliability. 
Reporting validity/reliability allows other researchers to assess measurement error and 
the data’s reliability impact on effect sizes and statistical power (Henson, 2001). This, in 
turn, affects the meta-analytic thinking process (Cumming & Finch, 2001).   
In addition, only 39% of articles used a multivariate analysis, which has the 
ability to examine several independent and dependent variables concurrently.  Two 
articles referred to using a step-wise regression analysis, which has, itself, important 
limitations (see Thompson, 2006 for an overview of the shortcomings of step-wise 
analyses). Thus, even a cursory examination of methodological quality, such as this one, 
reveals that research on this topic holds room for improvement in its methods and 
approaches.  
 To our knowledge, this is the first extensive review including articles before and 
after the approval of the HPV vaccine for males and females focusing on healthcare 
providers’ knowledge, attitudes, intentions, perceptions, and professional practice 
regarding the HPV vaccine for youth. This review points to several noteworthy findings. 
First, healthcare providers’ HPV vaccine knowledge appeared to have less variation than 
knowledge about the virus itself. Additionally, the majority of participants in the 
reviewed studies reported feeling comfortable discussing sexuality issues with patients. 
However, an earlier review, published in 2006, cited studies showing healthcare 
providers’ reluctance to discuss sexuality issues (Zimet, 2006).  Healthcare providers’ 
knowledge and comfort level is important because accurate information and effective 
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communication skills will impact the success of HPV vaccination programs (Zimet, 
2005).  
 Second, although most healthcare providers support the HPV vaccine, the main 
perceived barrier to administering the vaccine was “cost”. Other barriers included 
parent/patient safety concerns, and parents’ concerns the HPV vaccine will increase 
risky sexual behaviors, even though few healthcare providers had this concern 
themselves.  
 Because parents’ concerns about the HPV vaccine safety, side effects, and 
increasing sexual activity (Bartlett & Peterson, 2011; Herzog et al., 2008; Jenson, 2009; 
Kessels et al., 2012) may be perceived as barriers to vaccinating against HPV, it is vital 
to examine all dimensions of parents’ knowledge and attitudes and how these relate to 
providing healthcare services. Numerous literature reviews and studies reported poor or 
low knowledge about HPV prior to the vaccine’s approval (Gamble et al., 2010; Kollar 
& Kahn, 2008; Zimet, 2006). However, a recent literature review indicated a majority of 
parents had at least heard of HPV and the HPV vaccine (Bartlett & Peterson, 2011). 
Contrary to beliefs that parents are opposed to the HPV vaccine, reports have found 
parents are willing and interested in vaccinating their children against HPV (Brewer & 
Fazekas, 2007; Gamble et al., 2010; Herzog et al., 2008; Jenson, 2009; Zimet, Liddon, 
Rosenthal, Lazcano-Ponce, & Allen, 2006). Parents favor protecting their child from a 
serious infection, with a vaccine, despite the infection source (Zimet et al., 2006).  
Furthermore, a review by Gamble et al. (2010) showed adolescents’ acceptance of 
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vaccines against sexually transmitted infections is high. Despite this documented 
acceptance of the HPV vaccine, uptake rates among adolescents are still low in the US. 
 Given the high levels of acceptance and interest, the professional/scientific 
literature has identified healthcare providers’ (e.g., physicians, pediatricians) 
recommendations as being associated with positive parental and patient attitudes toward 
vaccinations. Providers’ recommendations are also associated with  increased vaccine 
rates (Brewer & Fazekas, 2007; Fisher et al., 2008; Gamble et al., 2010; Garcini, Galvan, 
& Barnack-Tavlaris, 2012; Jenson, 2009; Kessels et al., 2012; Zimet, 2005; Zimet et al., 
2006; Zimet, 2006). Healthcare providers have an important role in providing patient 
education (i.e., addressing concerns and clarifying misunderstandings) about HPV and 
the HPV vaccine (Brewer & Fazekas, 2007; Jenson, 2009; Zimet, 2006). Healthcare 
providers’ attitudes and recommendations will continue to influence parents’ and 
patients’ HPV vaccine views (Herzog et al., 2008; Jenson, 2009).  
 In this review, professional organizations’ and other professionals’ 
recommendations were identified as factors associated with intending to administer or 
administering the HPV vaccine. This finding is consistent with other reviews which 
found endorsements from professional organizations (such as the American Academy of 
Family Physician, CDC, and the American Academy of Pediatrics/Redbook) were 
factors for accepting or intending to recommend the HPV vaccine (Gamble et al., 2010; 
Zimet, 2005; Zimet et al., 2006; Zimet, 2006).  
Furthermore, other predictors of intention to recommend the HPV vaccine 
included the patient being female, the patient being older in age, HPV knowledge, and 
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providers’ gender. Age was also a factor in vaccinating against HPV when comparing 
older adolescents’ vaccination rates to younger adolescents. Confirming these findings, 
other reviews reported older adolescent patients (Zimet, 2005; Zimet et al., 2006; Zimet, 
2006), as well as female patients (Zimet, 2005; Zimet et al., 2006) were more likely to 
receive a recommendation from a healthcare provider. Given that the CDC 
recommendation for the HPV vaccine is for 11-12 year old girls and boys (CDC, 
2013d); there is cause for concern that healthcare providers in these studies are reluctant 
to vaccinate males and younger adolescents. This same issue was documented by Zimet 
et al. in 2006, and seven years later still remains a concern.    
 A majority of these studies focused on healthcare providers’ attitudes, intentions, 
and practices regarding the HPV vaccine for female adolescents. There should be more 
research regarding healthcare providers’ HPV vaccine recommendation to male patients. 
Encouraging both males and females to receive the vaccine simplifies educational efforts 
by the medical and health promotion professions and implies the collective responsibility 
of helping prevent both cervical cancer and genital warts (Schnatz et al., 2010). 
Including males in the vaccination process also can reduce HPV related cancers among 
men, prevent genital warts, and reduce the transmission of HPV to uninfected women 
(Ault, 2008).  
Although the studies reviewed here yield valuable information about healthcare 
providers in general, there were no studies assessing school nurses and their views of the 
HPV vaccine. This is particularly intriguing, given school nurses’ prominent role as 
healthcare providers for adolescents and school age children. Because school nurses are 
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viewed as health advocates for children (Bartlett & Peterson, 2011), school nurses have 
an important role in providing accurate information about HPV and the HPV vaccine, as 
well as in recommending the vaccine to parents and students (Bartlett & Peterson, 2011; 
Ehrhardt, 2007). Since the HPV was approved and became widely available, there is a 
need to monitor the attitudes, beliefs, and behaviors of all populations involved in HPV 
vaccine acceptance (Zimet et al., 2006), including school nurses. 
Limitations 
 Although this review contributes to the literature by synthesizing research on 
healthcare providers’ knowledge, attitudes, perceptions, intentions and practices related 
to the HPV vaccine, it has limitations that must be considered. First, this review 
excluded qualitative research regarding the HPV vaccine. The purpose of this review 
was to summarize and describe the results of empirical quantitative studies assessing 
healthcare providers’ knowledge, attitudes, and/or professional practice. Quantitative 
studies utilizing inferential statistics allow for generalizability in understanding 
healthcare providers’ knowledge, attitudes, perceptions, intentions and professional 
practice towards the HPV vaccine in youth. Future reviews could include qualitative as 
well as quantitative studies to provide a richer assessment and specific cases regarding 
this issue.  
In addition, this study excluded research conducted in countries other than the 
US. Although examining studies conducted in other countries would have limited the 
generalizability of the findings in this review, future reviews could synthesize the 
variability in the HPV vaccine uptake across countries (Kessels et al., 2012). In this 
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review, we chose to focus exclusively on American healthcare providers, which allowed 
us to understand the issue from a single cultural perspective.   
Despite these limitations, this review provides the first study examining and 
organizing literature exclusively focusing on healthcare providers regarding the HPV 
vaccine for youth. Findings identified that healthcare providers are more likely to 
recommend the HPV vaccine or vaccinate if (a) professional organizations recommend 
the HPV vaccine, (b) the patient is female and older, and (c) if there are fewer perceived 
barriers to vaccination. These findings suggest the medical and health promotion 
professional must rely on a multi-dimensional approach to understanding adolescent 
vaccine acceptance and increasing vaccination rates (Katz et al., 2010).   
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CHAPTER IV 
SCHOOL NURSES' KNOWLEDGE, ATTITUDES, PERCEPTIONS, AND 
PROFESSIONAL PRACTICE REGARDING HPV VACCINE FOR YOUTH 
 
Introduction 
Since 2006, adolescents in the United States (US) have had an effective means of 
preventing cervical cancer and genital warts: the human papillomavirus (HPV) vaccine. 
Despite such effective means, vaccination rates remain low for adolescents. Since the 
vaccine’s approval, 53% of female and 8.3% of male adolescents have been vaccinated 
with the first of three required doses. Yet only 34.8% of teen females have received all 
three recommended doses. Currently, males’ three dose vaccination rates are not 
reported (Centers for Disease Control and Prevention [CDC], 2012a).  
One important question, therefore, emerges from this low uptake scenario: What 
can healthcare providers do to increase the uptake of the HPV vaccine? Although 
informing parents about the vaccine’s benefits is an important factor—research shows 
parents are concerned about the vaccine’s safety, side effects, and potential for 
increasing sexual activity of adolescents (Bartlett & Peterson, 2011; Herzog et al., 2008; 
Jenson, 2009; Kessels et al., 2012)—the scientific literature documents healthcare 
providers’ recommendations can lead to positive parental/patient attitudes toward 
vaccinations and increased vaccination rates (Brewer & Fazekas, 2007; Fisher et al., 
2008; Gamble et al., 2010; Garcini et al., 2012; Jenson, 2009; Kessels et al., 2012; 
Zimet, 2005; Zimet et al., 2006; Zimet, 2006). Healthcare providers, therefore, play an 
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important role because they can clarify misunderstandings and concerns about the HPV 
vaccine, as well as influence parents/patients’ perspectives (Brewer & Fazekas, 2007; 
Jenson, 2009; Zimet, 2006).  
Even though school nurses are the most readily available healthcare professionals 
to families with adolescents (Bennett, 2008), there is limited literature exploring school 
nurses’ role regarding the HPV vaccine for youth (see Chapter III). This study, therefore, 
examines school nurses’ knowledge, attitudes, perceptions, and professional practice 
regarding the HPV vaccine for youth in the US. 
School Nurses as Opinion Leaders  
 As described in Chapter II, the Diffusion of Innovations (DOI) theory is an ideal 
framework to examine school nurses as opinion leaders regarding the HPV vaccine for 
youth. Diffusion of innovations is a process “by which (1) an innovation (2) is 
communicated through certain channels (3) over time (4) among the members of a social 
system” (Rogers, 2003, p. 11). Within social systems, there are opinion leaders 
communicating with and influencing other members’ attitudes and behaviors regarding 
the innovation over a certain time period. Opinion leaders are vital to the success or 
failure of diffusion programs (Rogers, 2003), because opinion leaders communicate with 
other people and act as influential channels (Green et al., 2009; Valente & Pumpuang, 
2007). 
 School nurses can be considered opinion leaders within the school-community 
systems because of their unique role as cross-disciplinary professionals and their 
understanding of the educational and health systems (Baisch et al., 2011; American 
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Academy of Pediatrics Council on School Health, 2008). Because school nurses are an 
important element in delivering current healthcare information to students and parents, 
these professionals have the opportunity to provide appropriate HPV vaccine 
information and recommendations, thereby allowing parents to make informed decisions 
regarding the HPV vaccine for their children (Bartlett & Peterson, 2011; Ehrhardt, 
2007). Particularly, school nurses can address parents’ concerns about necessity, safety, 
and efficacy to lessen apprehensions about the vaccine (Lockwood-Rayermann & 
McIntyre, 2009). School nurses are able to connect with a large portion of the 
population—nearly all school-aged adolescents—thus having the ability to disseminate 
vital information about cervical cancer prevention (Lockwood-Rayermann & McIntyre, 
2009). As a result, school nurses serve as interpersonal communication channels 
between various educational and medical professionals and parents. 
The Model and Research Questions 
To understand school nurses’ role as opinion leaders, their knowledge and 
attitudes regarding the HPV vaccine for youth, as opinion leaders affect the diffusion 
process need to be examined (Rogers, 2003). According to the DOI theory, the 
knowledge stage is when an individual learns of an innovation and understands the 
innovation’s function. The knowledge stage then leads to the persuasion stage. It is 
during the persuasion stage of the innovation-decision process that school nurses will 
develop favorable or unfavorable attitudes about the HPV vaccine. School nurses’ 
communication channels, which may include other school nurses, physicians, and 
clinical nurses, help in developing and shaping these attitudes. The underlying 
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assumption is that the behavior will follow, after the attitude is formed (Rogers, 2003). 
For example, if attitude toward the HPV vaccine is favorable, the vaccine will be 
accepted. However, such direct correlation between behavior and attitude does not 
always occur, or action does not always match attitude. This inconsistency is known as 
the KAP-gap (KAP stands for knowledge, attitude, and practice; Rogers, 2003).  
To date, US school nurses' KAP-gap regarding the HPV vaccine for youth has 
not been empirically examined (see Chapter III). Furthermore, US school nurses’ 
perceptions of their role as opinion leaders regarding the HPV vaccine have not been 
assessed. Therefore, we have proposed a model to explain school nurses professional 
practice regarding the HPV vaccine. The model includes knowledge and attitudes 
concerning HPV and the HPV vaccine, and school nurses’ perceptions of their role as 
opinion leaders. The model proposes that knowledge impacts attitudes, perceptions, and 
professional practice. Additionally, the model suggests attitudes influence perceptions 
and professional practice, and that perceptions affect professional practice. These 
relationships are displayed in Figure 4.1. 
In this study, we report on a survey designed to answer: (1) what are US school 
nurses’ knowledge, attitudes, perceptions of their role as opinion leaders, and 
professional practice regarding HPV vaccine for youth, (2) and do knowledge, attitudes, 
and perceptions of being an opinion leader influence US school nurses’ professional 
practice regarding the HPV vaccine for youth? 
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Figure 4.1. Proposed model for the relationships among school nurses’ knowledge, 
attitudes, perceptions of their role as opinion leaders, and professional practice regarding 
HPV vaccine for youth in the US. 
 
 
Methods 
Sample Selection and Size 
 To draw from a wide geographic area, we utilized the National Association of 
School Nurses’ (NASN) member database, comprising of an estimated 15,000 members. 
Members of the NASN are school nurses practicing in various school settings in both 
public and private schools. A minimum of 378 participants' completed online surveys 
were needed for statistical inference based on the 15,000 members in NASN. This 
minimum number was derived taking into account a 95% confidence level with a 5% 
sampling error and a 50/50 spilt (i.e., a varied distribution of the effects among the 
population; Salant & Dillman, 1994). Because online survey response rates vary between 
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27% and 56% (Cook, Heath & Thompson, 2000; Kittleson, 1997; Kittleson & Brown, 
2005), approximately 1,375 NASN members were recruited (taking into account the 
conservative estimate of 27% response rate). An extra 400 members were sampled to 
account for any returned or undeliverable email addresses or if a participant 
acknowledged no longer being a school nurse (68 of these were included in the final 
sample). Thus, the NASN systematically sampled 1,775 members (e.g., participants 
selected by every nth number) from their database using IMpak (Integrated Software 
Solutions, Inc.), and a total of 1,443 school nurses were invited to participate, with the 
final sample size including 505 participants. 
Measures 
 An online survey instrument was designed to measure: demographic 
characteristics, knowledge of HPV and of the HPV vaccine, attitudes regarding HPV and 
the HPV vaccine, perceptions concerning school nurses’ role as opinion leaders for the 
HPV vaccine, school nurses’ professional practice in providing education/resources 
about the HPV vaccine, and school districts’ support in providing health education in 
general. Three experts in health promotion and three school health experts/school nurses 
reviewed the items to assess construct relevance, content accuracy, technical flaws, 
grammar, offensiveness and readability (DeVellis, 2003). Four people, who were 
graduate students in health education and school professionals, assisted by participating 
in cognitive interviews and provided feedback for all the items (Dillman, 2007). See 
Appendix A for the instrument. 
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 Demographic Characteristics. Participant characteristics were obtained and 
assessed using items related to gender, race/ethnicity, role within the school, school 
setting, and grade level currently serving. Additionally geographic population, age, years 
working as a nurse, years working in the school environment, number of students the 
participant currently serves, and number of school buildings currently served were 
assessed. 
Knowledge Index. To assess if school nurses were familiar with basic 
knowledge concerning HPV and its vaccine, a knowledge index with 14 multiple choice 
items was created, based on the CDC and the National Institutes of Health (NIH) 
websites’ on HPV and HPV vaccination information and guidelines (CDC, 2013c; 
National Cancer Institute, 2011). Participants’ scores were measured through counting 
the number of correct responses (range 0-14) and, in our sample, exhibited a Cronbach's 
alpha of 0.61. A higher score meant higher knowledge of HPV and the vaccine. HPV 
knowledge included items on prevalence, symptoms, and transmission. HPV vaccine 
knowledge items included vaccination population, administration, protection, and 
vaccination types. To see the table of item specifications for the knowledge index refer 
to Table 4.1. 
 
 
 
 
 
 79 
 
Table 4.1  
Item Specifications for Knowledge Index 
 
Constructs 
Percent of Knowledge 
Items per Construct 
HPV Prevalence 14% 
HPV Health Symptoms 22% 
HPV Spread 7% 
HPV Vaccine Population 22% 
HPV Vaccine Administration 14% 
HPV Vaccine Protection 7% 
HPV Vaccine Types 14% 
TOTAL 100% 
 
 
 Attitudes. This variable is a latent variable in the proposed model with two sub-
scales measuring attitudes towards (1) HPV and (2) the HPV vaccine. Responses for 
these sub-scales comprised a four-point Likert rating (1 = strongly disagree, 4 = strongly 
agree). Similar to the knowledge items, the attitude items were created based on the 
CDC and the NIH websites’ HPV and HPV vaccination information and guidelines. We 
also anchored the items on the Theory of Planned Behavior (Montano & Kasprzyk, 
2008), which states attitudes are formed by the linear combination of beliefs and values. 
Belief items had a corresponding value item and pairs of items were linearly combined 
(i.e., attitudes were formed by the sum of belief items multiplied by their respective 
value items) to measure participants’ attitudes.  
HPV Sub-scale. This sub-scale contained three items measuring school nurses’ 
attitudes towards the health risks of HPV. A Cronbach’s alpha of 0.64 was obtained for 
this scale. Higher scores indicated attitudes of viewing HPV as causing serious health 
issues.  
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HPV Vaccine Sub-scale. This sub-scale contained 11 items assessing school 
nurses’ attitudes towards the HPV vaccine’s safety and efficacy, and the population that 
should be receiving the HPV vaccine. The reliability level (Cronbach's alpha) for this 
sub-scale was 0.92. Higher scores indicated positive attitudes towards the HPV vaccine.  
 Perceptions. This scale was also created for this study and based on the DOI’s 
construct of opinion leaders (Rogers, 2003). This scale comprised three items that 
produced a Cronbach’s alpha of 0.82. An example of the scale’s item is “I currently see 
myself as a leader in providing HPV vaccine information in the school community.” 
Responses fell on four-point Likert scale (1 = strongly disagree, 4 = strongly agree), 
with higher scores indicating stronger perceptions of being an opinion leader. As with 
the attitudes scale, a linear combination of belief and value items were used in creating 
this scale.  
 Professional Practice. This is also a latent variable consisting of two sub-scales: 
(1) providing HPV vaccine resources and information to parents and students, and (2) 
school district support for school nurses providing health education. 
Providing HPV Vaccine Information and Resources to Parents and Students 
Sub-Scale. This sub-scale comprised of seven items, specifically created for this study, 
and yielded a Cronbach’s alpha of 0.90. Items measured school nurses’ professional 
practice of providing information and resources about the HPV vaccine to parents and 
students. Participants had a 4-point scale for response options, anchored by 1 (never) and 
4 (always). Participants had a fifth response option of “policies in the school 
district/campus I work in/at do not allow this.” This fifth response option was treated as 
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missing data in the model. Higher scores indicated engaging in more professional 
practice providing information and resources about the HPV vaccine to parents and 
students.   
 School District Support for School Nurses Providing Health Education. This 
sub-scale contained four items assessing school districts’ support of school nurses 
providing health education (in general, not specifically related to HPV). The scale 
exhibited a Cronbach's alpha of 0.89. The items were scored on a 4-point Likert scale (1 
= strongly disagree, 4 = strongly agree). Therefore, higher scores denoted higher levels 
of district support for health education provided by the school nurse. 
Data Collection 
 The instrument questions were entered into Qualtrics, an online software 
program provided by Texas A&M University to faculty, staff, and students, for 
administering online surveys. Qualtrics generated a link to the survey, which was sent 
via email along with a description of the study to participants during January 2013. The 
email's subject line was left blank, because research suggests that emails not stating the 
reason or the sponsor of the email are more likely to be opened by participants (Porter & 
Whitcomb, 2005).  The survey was distributed through a mail merge option three 
separate times (the initial email followed by two email reminders) in a two-week period. 
The first email reminder was sent one week after the initial survey email, and the second 
email reminder was sent two weeks after the initial survey email.   
 Qualtrics has an “authenticator” option, which requires participants to log in with 
their email address to avoid data duplication. Qualtrics also allows for survey items to be 
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randomized within the survey to reduce the chance of a response set. Both the 
authenticator option and randomization of items were utilized in this study. A random 
drawing of 20 email addressesprovided by the participantsfor receiving a $50 Wal-
Mart gift card was used to provide incentives for the participants. Using monetary 
incentives has been shown to increase the likelihood of participation in online surveys 
and may improve the quality of participants’ responses (Göritz, 2010). This study and 
the instrument were reviewed and approved by Texas A&M University Institutional 
Review Board (IRB) and by the National Association of School Nurses.  
Data Analysis 
A total of 505 participants responded to the survey, yielding a response rate of 
34.9%.  The final dataset, however, had cases with missing data. Cases were deleted if 
there were missing data for more than three items. If only three or fewer items were 
missing, average scores were imputed. Data analyses were conducted with cases that had 
no missing data, exclusively, yielding a final sample size of 413 (response rate 28.6%).  
Descriptive statistics and frequencies were conducted to analyze participant 
characteristics’ data. Analysis of Variance (ANOVA) was used to examine zero-order 
differences between three nominally-scaled demographic variables—geographic area, 
grade level currently serving, and race/ethnicity with a cutoff of α = 0.05. Pearson’s r 
correlation was conducted for the demographic variable of years working in a school 
environment as a nurse, which was a continuous variable with a cutoff of α = 0.05. 
Effect sizes were computed and reported for all mean differences. Because there was 
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such a large group of respondents identifying as White in race/ethnicity (95.9%), this 
variable was further dichotomized as White and non-White in the analyses. 
An exploratory factor analysis (EFA) with the attitudes, perceptions, and 
professional practice scales, allowed assessing these scales’ factor structure and whether 
the scales exhibited internal consistency. Additionally, the proposed model was 
examined through structural equation modeling (SEM) techniques because of its ability 
to examine the adequacy of theorized models. Model fit was evaluated with the 
comparative fit index (CFI), incremental fit index (IFI), and root mean square error of 
approximation (RMSEA), with a 90% confidence interval (Browne & Cudeck, 1993; Hu 
& Bentler, 1998). Direct and indirect effects were also analyzed. All analyses were run 
in PASW Statistics 18.0 and Amos 5 (SPSS Inc., 2007; SPSS Inc., 2010).  
Results 
Demographic Characteristics 
 Participants in this study were, on average, 51 years old (SD = 8.7), ranging 
between 25 and 74. The item assessing the number of years working as a nurse had a 
mean of 26.4 (SD = 9.9), and years in the school environment as a nurse had a mean of 
11.7 (SD = 7.5). The majority of participants were female (n = 409, 99.0%), White (n = 
396, 95.9%), registered nurses (RN; n = 384, 93.0%), and working in a public school (n 
= 373, 90.3%). Nearly half of the sample identified working in a rural area (n = 203, 
49.2%), and were currently serving grade levels 9
th
-12
th
 (n = 204, 49.4%), followed by 
6
th
-8
th
 (n = 114, 27.6%), and Pre-Kindergarten (PreK)-5
th
 (n = 95, 23.0%). Tables 4.2 
and 4.3 provide additional participants’ characteristics.   
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Table 4.2 
Study Participant Characteristics on Continuous Variables (n = 413) 
Variable M SD 
Age 51.1 8.76 
Years as a Nurse 26.4 9.9 
Years in the School Environment as a     
     Nurse 
11.7 7.5 
Number of Students Currently  
     Serving 
2,359.9 9,647.9 
Number of School Buildings  
     Currently Serving 
3.9 8.2 
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Table 4.3 
Study Participant Characteristics on Non-Continuous Variables (n = 413) 
Variable n % 
Gender (n = 413)   
 Female 409 99.0 
 Male 4 1.0 
Race/ethnicity (n = 413)   
 White 396 95.9 
 Black or African American  7 1.7 
 Hispanic or Latino 6 1.5 
 American Indian or Alaska Native  3 0.7 
 Asian 1 0.2 
 Native Hawaiian or other Pacific 
Islander 
0 0.0 
Role within School (n =413)   
 Registered nurse (RN) 384 93.0 
 Registered nurse practitioner  10 2.4 
 Practical nurse (LPN) 6 1.5 
 Retired  6 1.5 
 Other  5 1.2 
 Vocational nurse (LVN) 2 0.5 
 Nurse's assistant 0 0.0 
Geographic Area Population (n = 413)   
 Rural ( ≤ 100,000 people) 203 49.2 
 Urban ( <500,000  and  > 100,000 
people) 
144 34.9 
 Metropolitan ( ≥ 500,000 people) 66 16.0 
School Setting (n=413)   
 Public 373 90.3 
 Private 17 4.1 
 Other  14 3.4 
 Charter 5 1.2 
 Parochial 4 1.0 
Grade Levels Currently Serving (n = 413)   
 9
th
-12
th
 grade 204 49.4 
 6
th
-8
th
 grade 114 27.6 
 PreK-5
th
  grade 95 23.0 
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Research Questions 
Research Question 1: What are US school nurses’ knowledge, attitudes, 
perceptions of their role as opinion leaders, and professional practice regarding 
the HPV vaccine for youth? 
Knowledge. The mean score for the knowledge scale was 10.0 (SD = 2.4) with 
scores ranging between 2-14 with the maximum possible score being 14, suggesting that 
school nurses have some knowledge of HPV and the vaccine.  The main item that 
received the most incorrect responses was “At least ___ of sexually active people have 
been infected with HPV at some point in their lives” with only 38% of participants 
providing the correct response of 50%.  
 Based on the knowledge scale, an ANOVA revealed a statistically significant 
difference for participants serving 9
th
-12
th
 grades (M = 10.3, SD = 2.3) when compared 
to participants serving PreK-5
th
 grades (M = 9.3, SD = 2.5); knowledge scores from 
school nurses serving 9
th
-12
th
 grades were higher (F [2, 410] = 5.0, p = .007, 2 = 2.4%). 
Additionally, based on race and ethnicity, White participants scored significantly higher 
on knowledge (M = 10.0, SD = 2.3), compared to non-White participants (M = 8.5, SD = 
2.8, F [1, 411] = 7.5, p = .007, 2 = 1.9%).  
Attitudes. Participants’ attitudes towards the HPV vaccine were, mostly, positive 
with a scale mean of 122.0 (SD = 27.6) and ranging between 53-176. All but one item in 
the HPV vaccine sub-scale had a mean above 10.00, and individual items had a range 
from 1-16. The one item scoring lower than all others regarded the HPV vaccine being 
on the market long enough to be considered safe (M = 8.7, SD = 2.6). An ANOVA 
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showed school nurses working in a metropolitan area had more positive attitudes 
towards the HPV vaccine (M = 130.2, SD = 25.7) than participants working in a rural 
area (M = 120.4, SD = 28.0, F [2, 410] = 3.5, p = .03, 2 = 1.7%). 
 Participants were more “middle-of-the-road” about HPV.  The mean score for the 
item was 26.6 (SD = 9.0), with scores ranging from 9-48. Race/ethnicity differences in 
scoring were statistically significant, with White participants reporting that HPV was 
considered serious in terms of causing health issues more than non-White participants 
(MWhite = 26.8, SD = 9.0; Mnon-White = 22.3, SD = 7.3, F [1, 411] = 4.0, p = .05, 
2 
= 
1.0%). 
Perceptions of Role as Opinion Leaders. On average, school nurses in our 
study scored slightly above the conceptual mid-point of the scale (ranging from 8–48; M 
= 26.5, SD = 8.4). These scores indicate less-than-enthusiastic perceptions of their role 
as opinion leaders regarding the HPV vaccine. When comparing sub-groups of 
participants through ANOVA, scores on the factor “perceptions of role as opinion leader 
for the vaccine” exhibited statistically significant differences for geographic area, grade 
level, and years working in the school environment. Participants working in a 
metropolitan area (population of 500,000 people or more) had stronger perceptions of 
being an opinion leader for the HPV vaccine (M = 28.7, SD = 9.0) than participants 
working in an urban area (population between 100,000 and 500,000 people; M = 25.9, 
SD = 7.5, F [2, 410] = 3.1, p = 0.05, 2 = 1.5%). However, there was no difference 
between school nurses working in rural areas when compared to school nurses working 
in urban and metropolitan areas. School nurses who were currently working with 
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students in 9
th
-12
th
 grades had stronger perceptions of being an opinion leader (M = 
27.5, SD = 8.9) when compared to those working with students in PreK-5
th
 grades (M = 
24.1, SD = 7.0, F [2, 410] = 5.3, p = 0.005, 2 = 2.5%). Furthermore, we examined 
whether the variable “years working in the school environment” was correlated with 
“perceptions of being an opinion leader” by running a Pearson r. The association was 
statistically significant, but small (p = 0.02, r = 0.12); the longer a school nurse worked 
in the school environment the stronger his/her perceptions were of being an opinion 
leader.  
Professional Practice. Overall, school nurses in our study reported few 
professional practice activities related to providing information and resources about the 
HPV vaccine, with a mean scale score of 11.7 (SD = 4.8; scale range of 7-28). However, 
participants had a higher score for the sub-scale “district support” (M = 12.6, SD = 1.9; 
scale range of 5-16). 
 When exploring possible sub-group variation in professional practice of 
providing resources—such as those related to demographic variables—differences were 
statistically significant for grade level currently serving, race/ethnicity, and years 
working in the school environment. An ANOVA was computed and showed school 
nurses serving 9
th
-12
th
 grades were providing more information and resources (M = 13.3, 
SD =5.3) than those serving 6
th
-8
th
 grades (M = 11.0, SD =4.0, p = 0.00), or PreK-5
th
 
grades (M = 9.2, SD =3.1, F [2, 388] = 28.0, p < 0.001, 2 = 12.6%). The difference 
between scores from school nurses serving 6
th
-8
th
 grades and those serving PreK-5
th
 
grades was also statistically significant (p = 0.02). Regarding race/ethnicity, non-White 
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participants reported engaging in providing information and resources about the HPV 
vaccine more frequently than White participants (MWhite = 14.6, SD =5.8; Mnon-White = 
11.6, SD = 4.7, F [1, 411] = 5.9, p = 0.02, 2 = 1.5%). Years working in the school 
environment was positively correlated (albeit a weak relationship) with providing 
information and resources for HPV vaccine (p = 0.001, r = 0.17). No statistically 
significant differences were observed regarding demographic variables and district 
support for nurses’ professional practice. Tables 4.4 through 4.6 provides the ANOVA 
results for each of the demographic variables (geographic population, grade level 
currently serving, and race/ethnicity), while Table 4.7 provides the Pearson's r results for 
“years working in the school environment” variable. Table 4.8 provides the means and 
standard deviations for total scale scores and the Cronbach’s alpha for each scale. To see 
the means and standard deviations for all individual items in the scales please see 
Appendix B through Appendix E. 
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Table 4.4      
ANOVA Results for Knowledge, Attitudes, Perceptions, and Professional Practice by Geographic 
Population 
 Metropolitan Urban Rural F 2 
Knowledge 9.8  
(1.9) 
9.7  
(2.6) 
10.2  
(2.3) 
2.1 1.0% 
Attitudes       
  HPV 
 
 
26.7  
(9.7) 
26.2  
(8.6) 
26.8  
(9.2) 
0.2 0.0% 
 Vaccine 
 
 
130.2a  
(25.7)  
120.6  
(27.4) 
120.4a 
(28.0) 
3.5* 1.7% 
Perceptions 28.7a 
 (9.0) 
25.9a 
(7.5) 
26.2 
(8.7) 
3.1* 1.5% 
Practice      
 Resources 
 
 
11.5 
(5.4) 
11.2 
(4.4) 
12.1 
(4.9) 
1.6 0.8% 
 School District 
Support 
12.6 
(1.8) 
12.6  
(1.9) 
12.7  
(1.9) 
0.1 0.0% 
Note. * = p ≤ 0.05, ** = p ≤ 0.01. Standard Deviations are presented in parenthesis below means. Means 
with differing subscripts within rows are statistically significantly different based on Tukey HSD post hoc 
tests.  
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Table 4.5      
ANOVA Results for Knowledge, Attitudes, Perceptions, and Professional Practice by Grade Level 
Currently Serving 
 9
th
-12
th
 grade 6
th
-8
th
 grade PreK-5
th
 grade F 2 
Knowledge 10.3a  
(2.3)
 
10.0 
(2.3) 
9.3a 
(2.5) 
5.0* 2.4% 
Attitudes       
  HPV 
 
 
27.0 
(9.3) 
26.4 
(8.5) 
26.0 
(9.0) 
0.5 0.2% 
 Vaccine 
 
 
123.2 
(27.6) 
122.5 
(28.2) 
118.9 
(26.9) 
0.8 0.4% 
Perceptions 27.5a 
(8.9) 
26.7 
(8.2) 
24.1a 
(7.0) 
5.3** 2.5% 
Practice      
 Resources 
 
 
13.3ab  
(5.3) 
11.0ac 
(4.0) 
9.2bc 
(3.1) 
28.0** 12.6% 
 School District Support 12.8 
(1.9) 
12.3 
(1.6) 
12.8 
(2.0) 
2.9 1.4% 
Note. * = p ≤ 0.05, ** = p ≤ 0.01. Standard Deviations are presented in parenthesis below means. Means 
with differing subscripts within rows are statistically significantly different based on Tukey HSD post hoc 
tests.  
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Table 4.6      
ANOVA Results for Knowledge, Attitudes, Perceptions, and Professional Practice by Race/Ethnicity 
 White Non-White F 2 
Knowledge 10.0 
(2.3) 
8.5 
(2.8) 
7.5** 1.8% 
Attitudes      
  HPV 
 
 
26.8 
(9.0) 
22.3 
(7.3) 
0.05 1.0% 
 Vaccine 
 
 
122.0 
(27.6) 
123.5 
(29.4) 
4.0* 0.0% 
Perceptions 26.4  
(8.3) 
28.4 
(10.5) 
1.0 0.2% 
Practice     
 Resources 
 
 
11.6 
(4.7) 
14.6 
(5.8) 
5.9* 1.5% 
 School District 
Support 
12.6 
(1.9) 
12.8 
(1.6) 
0.2 0.0% 
Note. * = p ≤ 0.05, ** = p ≤ 0.01. Standard Deviations are presented in parenthesis below means.  
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Table 4.7       
Pearson's r Correlation for Knowledge, Attitudes, Perceptions, and Professional Practice by 
Years Working in a School Environment 
 r p 
Knowledge -0.07 0.16 
Attitudes    
  HPV 
 
-0.03 0.61 
 Vaccine 
 
0.07 0.18 
Perceptions 
 
0.12* 0.02 
Practice   
 Resources 
 
0.17** 0.001 
 School District Support 0.07 0.17 
Note. * = p ≤ 0.05, ** = p ≤ 0.01.  
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Table 4.8    
Scale Scores and Reliability Statistic   
Scales M SD Cronbach's α 
Knowledge (14 items) 10.0 2.4 .61 
Vaccine (11 items) 122.0 27.6 .92 
HPV (3 items) 26.6 9.0 .64 
Perceptions (3 items) 26.5 8.4 .82 
Resources (7 items) 11.7 4.8 .90 
Support (4 items) 12.6 1.9 .89 
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Research Question 2: Do knowledge, attitudes, and perceptions of being an 
opinion leader influence US school nurses’ professional practice regarding the 
HPV vaccine for youth? 
Structural equation modeling analyses examined the proposed model (see Figure 
4.1), hypothesizing relationships among knowledge, attitudes, perceptions of role as 
opinion leader, and professional practice regarding the HPV vaccine. This model 
suggested knowledge impacts attitudes, perceptions, and professional practice. 
Additionally, this model proposed attitudes influence perceptions and professional 
practice, and that perceptions affect professional practice. Knowledge, attitudes, and 
perceptions had direct paths to professional practice, but knowledge and attitudes also 
had an indirect path to professional practice through perceptions.  
The first run of the proposed model resulted in a χ2 of 17.084 (N = 413, df = 6, p 
= 0.009), indicating a potentially good fit.  Moreover, the analyses yielded a CFI = .979, 
IFI = .979 and RMSEA = .067 (90% CI [0.031-0.105]).  Together, these results (the χ2, 
CFI, IFI and RMSEA) suggested the model fit the data adequately, with both CFI and 
IFI revealing a good model fit (Browne & Cudeck, 1993; Hu & Bentler, 1998). All paths 
were statistically significant except for the knowledge to perceptions path (p = .25) and 
the knowledge to practice path (p = .18; see Figure 4.2). 
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Figure 4.2. Proposed model for school nurses’ knowledge, attitudes, perceptions of role 
as opinion leader impact of professional practice regarding HPV vaccine for youth with 
standardized regression weights. 
 
 
 The proposed model was then modified, after examining the standardized 
regression weights and modification indices, by removing the knowledge-to-perceptions 
and the knowledge-to-practice paths (see Figure 4.3). This modified model produced the 
following results: χ2 = 20.238 (N = 413, df = 8, p = 0.009), CFI = 0.977, IFI = 0.977 and 
RMSEA = 0.061 (90% CI [0.028, 0.095]). Again, these results indicated good model fit 
and all paths exhibited a statistically significant coefficient.  
In testing the proposed model, we were particularly interested in the role of the 
“perceptions” variable as a mediator. There are four steps that must be completed (in 
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SEM) to establish full mediation (Baron & Kenny, 1986; Holmbeck, 1997): (1) attitudes 
must affect/relate to practice, (2) attitudes must affect/relate to perceptions, (3) 
perceptions must affect/relate to practice, and (4) attitudes’ relationship with practice, 
when the perceptions variable is in the model, must be zero. However, when the 
coefficient for the attitude-to-practice path is substantially reduced after including 
perceptions in the model (but does not equal zero), partial mediation occurs (Kenny, 
2013).  
Therefore, we ran a third model to examine these four steps. First, the factor 
“perceptions” was removed (see Figure 4.4), and revealed a standardized regression 
weight from attitudes-to-practice of 0.54 (p < 0.05). When adding perceptions to the 
model, the standardized regression weight from attitudes-to-practice was reduced to -
0.30 (p < 0.05), indicating that perceptions is a partial mediator in the modified model. 
Furthermore, the standardized regression weight for attitudes-to-perceptions was 0.70 (p 
< 0.05) and perceptions-to-practice was 1.06 (p < 0.05). Standardized indirect effects for 
the path from attitudes-to-practice equaled 0.739 (p < 0.001). Thus, the net impact of 
perceptions as a mediating variable is positive and exerts a stronger indirect effect upon 
practice than a direct effect.  
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Figure 4.3. Modified model for school nurses’ knowledge, attitudes, perceptions of role 
as opinion leader impact of professional practice regarding HPV vaccine for youth with 
knowledge paths removed from perceptions and practice and standardized regression 
weights. 
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Figure 4.4. Modified model for school nurses’ knowledge, attitudes, and professional 
practice regarding HPV vaccine for youth with standardized regression weights. 
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Discussion 
 The purpose of this study was twofold: (1) to determine and qualify school 
nurses’ knowledge, attitudes, perceptions of their role as an opinion leader, and 
professional practice regarding the HPV vaccine for youth, and (2) to examine if 
knowledge, attitudes, and perceptions of their role as opinion leaders impact professional 
practice regarding this vaccine for youth. To our knowledge, this is the first study to 
examine school nurses’ cognitions and professional practice regarding HPV vaccine for 
youth in the US. Results from this study suggest school nurses have moderate 
knowledge regarding HPV and the HPV vaccine and mostly positive attitudes towards 
the HPV vaccine. School nurses' perceptions regarding their role as opinion leaders 
lacked strength, and their professional practice regarding the HPV vaccine for youth 
were infrequent.  
  Communication with parents and adolescents about the HPV vaccine is a critical 
component for increasing vaccination rates, and school nurses have a vital role in 
educating parents, students, and the community about receiving the HPV vaccine 
(Bartlett & Peterson, 2011; Ehrhardt, 2007). School nurses are particularly critical in the 
delivery of current health information, specifically information about the necessity, 
safety, and efficacy of vaccines (Lockwood-Rayermann & McIntyre, 2009). 
Furthermore, school nurses are the most common health services provider in the schools 
(Brener, Wheeler, Wolfe, Vernon-Smiley, & Caldart-Olson, 2007); they function as 
healthcare liaisons between students, school faculty and staff, families, healthcare 
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professionals, and the community (American Academy of Pediatrics Council on School 
Health, 2008). 
 Utilizing school nurses as opinion leaders to communicate information about the 
HPV vaccine could be an effective strategy in increasing HPV vaccination rates. School 
nurses have access to nearly all adolescents and in turn can have a profound impact on 
disseminating accurate information about the HPV vaccine (Lockwood-Rayermann & 
McIntyre, 2009). However, school nurses will be less-than-effective in disseminating the 
vaccine, if they do not consider themselves opinion leaders.  
 Overall, in this study school nurses appeared to have less-than-enthusiastic views 
of their role as opinion leaders regarding the HPV vaccine, shown in Table 4.8 with 
mean score of 26.5 out of 48. Despite their moderate perceptions, our analysis, as 
reflected in Figure 4.3 and 4.4, indicated an important mediating role for perceptions, 
shaping the relationship between school nurses’ attitudes and professional practice as the 
standardized regression weight decreased from 0.54 to -0.30 when perceptions was 
included in the model. Our results, in Figure 4.3, clearly indicate that a school nurse’s 
attitudes about HPV and the HPV vaccine affect the perceptions of his/her role as an 
opinion leader, which, in turn, influences professional practice. Although school nurses 
are considered leaders in advocating and providing health services by others in the social 
system (American Academy of Pediatrics Council on School Health, 2008; Bartlett & 
Peterson, 2011; Lockwood-Rayermann & McIntyre, 2009), if they do not see themselves 
as opinion leaders regarding the HPV vaccine, then the diffusion of the HPV vaccine 
will take longer to occur.  
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In the past, the KAP surveys, used to explain a behavior in the DOI theory, have 
contributed bleak understanding to human behavior change (Rogers, 1973), hence the 
name KAP-gap. These past surveys showed knowledge and attitude change is more 
attainable than adoption of a new practice (or behavior; Rogers, 2003). However, based 
on the results of this study we can see how the partial mediation, seen in Figure 4.3 and 
4.4, of perceptions of being an opinion leader clarifies some of the inconsistencies found 
among studies examining knowledge, attitudes and practice. This partial mediation is 
important when examining the relationship between attitudes and professional practice 
because perceptions of being an opinion leader provides an explanation of why school 
nurses might have high knowledge, and positive attitudes towards the HPV vaccine but 
low levels of professional practice (or provision of the vaccine and information). 
Therefore, by including a perceptions construct into KAP, we may be able to understand 
the past discrepancies between high knowledge, positive attitudes, and low practice.   
Another notable finding, in Figure 4.2, was that knowledge of HPV and the HPV 
vaccine did not influence perceptions of being an opinion leader nor professional 
practice regarding the HPV vaccine, which was reflected in the standardized regression 
weights. Conversely, some of the professional literature suggests that school nurses need 
more education about HPV and the HPV vaccine to promote and provide HPV vaccine 
information to parents and students (Ehrhardt, 2007; Lockwood-Rayermann & McIntyre, 
2009). While it is important that school nurses have correct information and knowledge 
of HPV and the HPV vaccine to provide to clients, this study revealed that more 
knowledge does not lead to stronger perceptions of being an opinion leader regarding the 
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HPV vaccine. Furthermore, higher knowledge levels were not directly related to 
providing parents and students with HPV vaccine information. This finding was 
consistent with another study focusing on healthcare providers showing there was no 
association between self-reported HPV knowledge and administering the HPV vaccine 
(Schnatz et al., 2010). Contradicting results showed healthcare providers’ HPV 
knowledge was associated with recommending and/or providing HPV vaccine (Kahn et 
al., 2009; Leddy et al., 2009). Knowledge of HPV and the HPV vaccine did, however, 
relate to attitudes as seen in Figure 4.2 with a standardized regression weight of 0.23. 
Therefore, having more knowledge of HPV and the HPV vaccine might be an important 
precursor for more positive attitudes towards the HPV vaccine.  
The last notable findings from this study were the differences found among 
various demographic variables. School nurses working in a metropolitan area 
(population of 500,000 people or more) and more years in the school environment 
reported stronger perceptions of being an opinion leader than school nurses working in 
an urban area (population between 100,000 and 500,000 people) and fewer years in a 
school environment, as reflected by the F-value of 3.1 and r of 0.12 in Table 4.4 and 
Table 4.7, respectively. These results could potentially be explained by having more 
experience in serving more studentswhether in a certain area or over timeand 
providing more education about health issues, thereby having stronger perceptions of 
being an opinion leader. Furthermore, this study found school nurses serving grades 9
th
-
12
th
 reported the highest levels of perceptions of themselves as opinion leaders and 
highest frequencies of professional practice as reflected by the F-value of 5.3 and 28.0, 
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respectively, in Table 4.5. These findings are consistent with results from a systematic 
literature review documenting that healthcare providers were more likely to recommend 
and provide the HPV vaccine to older adolescent patients than younger ones (Chapter 
III). The CDC recommends 11-12 year old boys and girls receive the HPV vaccine 
(CDC, 2013c), but with school nurses and healthcare providers offering information and 
recommendations mostly to older adolescents, there are missed opportunities to increase 
the HPV vaccination rates before sexual activity begins and when immune response is 
greatest (Ehrhardt, 2007). 
Based on these findings, when creating interventions to increase school nurses’ 
provision of HPV vaccine information, program developers need to focus more attention 
on increasing positive attitudes towards the HPV vaccine, and on school nurses’ 
perceptions of their role as opinion leaders for the HPV vaccine. While knowledge might 
be increased to assist in forming positive attitudes, increasing knowledge should not be 
the main focus of these programs. Additionally, school nurses serving all grade levels 
should be included in the interventions to encourage dissemination of positive attitudes 
among nurses serving younger adolescents. 
To our knowledge, this is the first nationally representative study of US school 
nurses’ knowledge, attitudes, perceptions of their role as opinion leaders, and 
professional practice regarding the HPV vaccine for youth. There are noteworthy 
strengths in this study. First, our study population comprised the members of the 
National Association of School Nurses, enhancing the generalizability of findings from 
our sample to US school nurses, nationally. Second, the survey instrument focused 
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specifically on the HPV vaccine, thereby allowing greater insight into school nurses’ 
views and professional practice regarding this vaccine. Third, by utilizing a robust 
multivariate analysis (SEM), we were able to create a model that allowed us to better 
understand which factors impact school nurses’ professional practice regarding the HPV 
vaccine. This, in turn, will allow for improving interventions and programs to help 
increase the HPV vaccine uptake among school-based youth. 
 Although this study had several strengths, specific limitations need to be 
considered when interpreting the results. First, participants were selected through 
systematic sampling (e.g., participants selected by every nth number) from the NASN 
database, thus the sample was not selected by true random sampling. Although this 
strategy allows for systematic bias to occur, the authors had no control over the required 
sampling strategy employed by the NASN. Second, while the response rate was decent 
for online surveys (34.9%), it may represent an underestimate of the true response rate, 
and such underestimation can be due to various factorssuch as spam 
filterspreventing potential participants from receiving the emailed survey link. This 
study's response rate may decrease the results’ generalizability to school nurses due to 
nonresponse bias. Finally, the data were self-reported; therefore we did not observe 
school nurses’ professional practice. Self-reported data have the potential for recall 
biases and responses that are socially-desirable. In an effort to minimize the latter, we 
included a 10-item social desirability scale, which revealed higher scores (ranging from 
0-10; M = 6.3, SD = 2.2) indicating some measure of participants providing socially-
desirable responses (Crowne & Marlowe, 1960).     
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Conclusions 
 Despite school nurses’ knowledge and positive attitudes towards the HPV 
vaccine, in our study’s sample, the actual practice of providing education to parents and 
students about the HPV vaccine can be strengthened. Furthermore, the model proposed 
in this study revealed that school nurses’ perceptions of their role as opinion leaders are 
influenced by their attitudes towards HPV and the HPV vaccine, which, in turn, affects 
their professional practice. These findings suggest that in order to foster professional 
practice regarding the HPV vaccine, the focus should be on increasing school nurses’ 
positive attitudes towards the HPV vaccine as well as strengthening perceptions of their 
role as an opinion leader. Schools with school nurses have been shown to have higher 
vaccination rates in general (American Academy of Pediatrics Council on School 
Health, 2008) and can address parents and students concerns and questions about 
vaccines (Lockwood-Rayermann & McIntyre, 2009). School nurses are, therefore, 
pivotal in the efforts to increase the uptake of the HPV vaccine among young people in 
this country and as such, they can contribute even more significantly than they have in 
the past to lowering the high rates of sexually transmitted infections among American 
youth.   
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CHAPTER V 
CONCLUSIONS 
 
The central purpose of this study was to provide insight into school nurses’ 
knowledge, views, and professional practice regarding the human papillomavirus (HPV) 
vaccine for youth. To this end, three independent articles were written: (1) a theoretical 
perspective describing the use of the Diffusion of Innovations (DOI) theory to explore 
school nurses’ role as opinion leaders regarding the HPV vaccine for youth (Chapter II), 
(2) a systematic literature review assessing healthcare providers’ knowledge, attitudes, 
intentions, perceptions, and professional practice regarding the HPV vaccine for youth 
(Chapter III), and (3) a survey study examining school nurses’ knowledge, attitudes, 
perceptions of role as an opinion leader, and professional practice providing education to 
parents and students regarding the HPV vaccine for youth in the United States (US).  
  To gauge the potentially positive role school nurses may have as opinion leaders 
in disseminating information and promoting vaccination acceptance among US 
adolescents, we proposed utilizing the DOI theory (Chapter II). Diffusion of novel 
information or innovations is a process “by which (1) an innovation (2) is communicated 
through certain channels (3) over time (4) among the members of a social system” 
(Rogers, 2003, p. 11). Opinion leaders are defined as members within a social system 
communicating with and influencing other social system members about the innovation 
over a certain time period. 
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We argued that school nurses can function as opinion leaders for the HPV 
vaccine because they hold a unique type of leadership position in that they are able to 
influence both programs and policies through their cross-disciplinary understanding of 
the educational and health systems (Baisch et al., 2011; American Academy of 
Pediatrics Council on School Health, 2008). Through representing the healthcare system 
to parents, school nurses are able to help educate parents about healthcare issues and 
decisions regarding their children’s health (Baisch et al., 2011; American Academy of 
Pediatrics Council on School Health, 2008).  
Because opinion leaders’ attitudes affect the diffusion process (Rogers, 2003), 
there is a need to understand school nurses’ knowledge, attitudes, and professional 
practice regarding the HPV vaccine. Sometimes, however, there are inconsistencies 
between knowledge and attitudes as they relate to practice (or implementation) of an 
innovation. This inconsistency is referred to as the knowledge, attitude, practice (KAP)-
gap (Rogers, 2003). In other words, a person might have high knowledge and positive 
attitudes towards an innovation, but not use the innovation. Thereby, the DOI theory 
offers a useful framework for researchers and practitioners in health promotion to 
understand the vaccine dissemination process and engage school nurses in promoting the 
HPV vaccine for youth. 
Systematically examining the current literature (Chapter III) revealed a lack of 
research on school nurses regarding the HPV vaccine for youth, although the 28 studies 
included in the systematic review provided valuable information about healthcare 
providers in general. Overall, healthcare providers were likely to recommend the HPV 
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vaccine if the patient was female, if the patient was an older adolescent, and if the 
healthcare provider perceived fewer barriers to vaccination.  Due to the HPV vaccine 
becoming widely available, there is a need to understand the beliefs, views, and 
behaviors of all populations involved in the HPV vaccine uptake (Zimet et al., 2006), 
including school nurses.    
The systematic review pointed to the importance of communication about the 
HPV vaccine for increasing acceptance and vaccination rates. School nurses have a 
critical role in communicating with, and educating parents and adolescents about 
receiving the HPV vaccine (Bartlett & Peterson, 2011; Ehrhardt, 2007).  
Surveying school nurses as healthcare providers provided a missing, yet 
innovative, perspective on the uptake of the HPV vaccine among adolescents (Chapter 
IV). Supporting the DOI theory’s notion of the KAP-gap, this study revealed school 
nurses had moderate levels of knowledge and positive attitudes regarding the HPV 
vaccine, but infrequent professional practice providing HPV vaccine education to 
parents and students. Moreover, testing of a proposed model with data from 413 school 
nurses from the National Association of School Nurses revealed perceptions of being an 
opinion leader regarding the HPV vaccine as being influenced by their HPV and HPV 
vaccine attitudes, and these, in turn, affected their professional practice.  
Results from the model testing imply that to increase school nurses’ professional 
practice, there should be a focus on strengthening their perceptions of being an opinion 
leader regarding the HPV vaccine in addition to improving their attitudes towards the 
HPV vaccine. School nurses have been shown to have an impact on vaccination rates in 
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general (American Academy of Pediatrics Council on School Health, 2008), and are able 
to address parents’ and students’ fears and questions about vaccines (Lockwood-
Rayermann & McIntyre, 2009). Thus, school nurses are vital in the attempt to increase 
HPV vaccination rates among US youth.   
 Our studies have important implications for research and practice. Further 
research on this issue, for instance, might focus on analyses of school nurses’ social 
networks, to examine the flow of information through communication channels which 
school nurses are exposed, and assess their role and position in these networks. 
Practitioners designing programs to engage school nurses in disseminating the HPV 
vaccine may benefit from questioning whether their programs might be emphasizing 
non-crucial elements for influencing vaccine dissemination practice (e.g., knowledge) 
and de-emphasizing elements that are, indeed, influential (e.g., perceptions of role as 
opinion leaders). 
 Despite its contributions, this dissertation is inherently limited by the choice of 
methods, rates of participation in the survey, and theoretical biases. Nonetheless, we 
believe the study represents an important first step in understanding the inclusion of 
school nurses in the effort to promote HPV vaccine uptake and, ultimately, to prevent 
unnecessary morbidity and mortality among youth in the US. 
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APPENDIX A 
SURVEY INSTRUMENT 
 
 
Demographics: The following items are to assess your current demographic 
information.  
 
What is your gender (select one response)? 
a. male  
b. female 
 
What is your current age in years (i.e., 65 years old)? 
_______years old 
 
What race/ethnicity do you MOST identify with (select one response)? 
a. American Indian or Alaska Native 
b. Asian 
c. Black or African American 
d. Hispanic or Latino 
e. Native Hawaiian or other Pacific Islander 
f. White 
 
Please select one of the following that best describes your role within the school (select 
one response):  
a. registered nurse (RN) 
b. vocational nurse (LVN) 
c. practical nurses (LPN) 
d. registered nurse practitioner 
e. nurse’s assistant 
f. retired  
g. Other 
 
How many years  (rounded to the nearest year) have you been or were a registered nurse 
(RN), vocational nurse (LVN), practical nurses (LPN), registered nurse practitioner, 
nurse’s assistant, or other? 
 
________years 
 
How many years (rounded to the nearest year) have you worked in the school 
environment as a registered nurse (RN), vocational nurse (LVN), practical nurses 
(LPN), registered nurse practitioner or nurse’s assistant? 
_______years 
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In which state do you currently work (including overseas military bases or US 
territories)?  
________ 
 
Which of the following describes the geographic area in which you currently work 
(select one response)?  
a. metropolitan (population 500,000 or more people)  
b. urban (population 100,000 or more and less than 500,000 people) 
c. rural (population less than 100,000 people) 
 
 
In what type of school setting do you work (select one response)? 
a. public  
b. private (school supported by private organization or private individuals)   
c. parochial (school supported by a church or parish)  
d. charter 
e. other____________ 
 
What grade level(s) are you currently serving this school year (select all that apply)? 
a. 12
th
 grade 
b. 11
th
 grade 
c. 10
th
 grade 
d. 9
th
 grade 
e. 8
th
 grade 
f. 7
th
 grade 
g. 6
th
 grade 
h. 5
th
 grade 
i. 4
th
grade 
j. 3
rd
 grade  
k. 2
nd 
grade 
l. 1
st
 grade 
m. Kindergarten 
n. Pre- Kindergarten 
 
Who is your employer (i.e., an independent school district, hospital, home health agency, 
etc.)? 
_________ 
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Attitudes (Beliefs): For the following items, please select the response that best 
represents your beliefs.  
 
I believe HPV causes major medical problems. 
a. strongly disagree 
b. disagree 
c. agree 
d. strongly agree 
 
I believe HPV is harmful to a person's health. 
a. strongly disagree 
b. disagree 
c. agree 
d. strongly agree 
 
I believe HPV weakens a person’s immune system. 
a. strongly disagree 
b. disagree 
c. agree 
d. strongly agree 
 
I believe HPV NEGATIVELY impacts a person’s wellness. 
a. strongly disagree 
b. disagree 
c. agree 
d. strongly agree 
 
I believe HPV is NOT a deadly virus. 
a. strongly disagree 
b. disagree 
c. agree 
d. strongly agree 
 
I believe for the majority of the population the HPV vaccine is safe. 
a. strongly disagree 
b. disagree 
c. agree 
d. strongly agree 
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I believe for the majority of the population there is little risk in receiving the HPV 
vaccine. 
a. strongly disagree 
b. disagree 
c. agree 
d. strongly agree 
 
I believe for the majority of the population the HPV vaccine is nontoxic (i.e., 
nonpoisonous, not dangerous). 
a. strongly disagree 
b. disagree 
c. agree 
d. strongly agree 
 
I believe for the majority of the population the HPV vaccine causes adverse health 
effects. 
a. strongly disagree 
b. disagree 
c. agree 
d. strongly agree 
 
I believe the HPV vaccine is effective at preventing HPV. 
a. strongly disagree 
b. disagree 
c. agree 
d. strongly agree 
 
I believe the HPV vaccine prevents cancers related to HPV. 
a. strongly disagree 
b. disagree 
c. agree 
d. strongly agree 
 
I believe the HPV vaccine prevents genital warts related to HPV. 
a. strongly disagree 
b. disagree 
c. agree 
d. strongly agree 
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I believe the HPV vaccine has NOT been on the market long enough to be considered 
safe. 
a. strongly disagree 
b. disagree 
c. agree 
d. strongly agree 
 
I believe students’ immune systems are weakened by the HPV vaccine. 
a. strongly disagree 
b. disagree 
c. agree 
d. strongly agree 
 
I believe that although the HPV  vaccine was FDA approved, the HPV vaccine is NOT 
safe. 
a. strongly disagree 
b. disagree 
c. agree 
d. strongly agree 
 
I believe the HPV vaccine is NOT effective at preventing HPV. 
a. strongly disagree 
b. disagree 
c. agree 
d. strongly agree 
 
I believe the HPV vaccine hinders HPV from infecting the person who received the 
vaccine. 
a. strongly disagree 
b. disagree 
c. agree 
d. strongly agree 
 
I believe the HPV vaccine improves students’ immune systems to defend against HPV. 
a. strongly disagree 
b. disagree 
c. agree 
d. strongly agree 
 
I believe ONLY female students should be vaccinated against HPV. 
a. strongly disagree 
b. disagree 
c. agree 
d. strongly agree 
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I believe ONLY male students should be vaccinated against HPV. 
a. strongly disagree 
b. disagree 
c. agree 
d. strongly agree 
 
I believe male and female students should be vaccinated against HPV. 
a. strongly disagree 
b. disagree 
c. agree 
d. strongly agree 
 
I believe preteens should receive the HPV vaccine. 
a. strongly disagree 
b. disagree 
c. agree 
d. strongly agree 
 
I believe preteens should receive the HPV vaccine before they become sexually active. 
a. strongly disagree 
b. disagree 
c. agree 
d. strongly agree 
 
I believe by providing my professional opinion, I influence parents to vaccinate their 
child/adolescent against HPV. 
a. strongly disagree 
b. disagree 
c. agree 
d. strongly agree 
 
I believe if I provide information to parents, they will vaccinate their child/adolescent 
against HPV. 
a. strongly disagree 
b. disagree 
c. agree 
d. strongly agree 
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I currently see myself as a leader in providing HPV vaccine information in the school 
community. 
a. strongly disagree 
b. disagree 
c. agree 
d. strongly agree 
 
 
Attitudes (Values): For the following items, please rank your agreement. 
 
It is important to me as a medical professional… 
 
for students to avoid major medical problems. 
a. strongly disagree 
b. disagree 
c. agree 
d. strongly agree 
 
to avoid harm when dealing with a person's health. 
a. strongly disagree 
b. disagree 
c. agree 
d. strongly agree 
 
for students to avoid a deadly virus. 
a. strongly disagree 
b. disagree 
c. agree 
d. strongly agree 
 
that a vaccine be safe. 
a. strongly disagree 
b. disagree 
c. agree 
d. strongly agree 
 
that a vaccine be nontoxic (i.e., nonpoisonous, not dangerous). 
a. strongly disagree 
b. disagree 
c. agree 
d. strongly agree 
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for students to avoid adverse health effects from vaccines. 
a. strongly disagree 
b. disagree 
c. agree 
d. strongly agree 
 
that a vaccine be on the market a certain amount of time to be considered safe. 
a. strongly disagree 
b. disagree 
c. agree 
d. strongly agree 
 
for students to have strong immune systems. 
a. strongly disagree 
b. disagree 
c. agree 
d. strongly agree 
 
for the HPV vaccine to be effective at preventing HPV. 
a. strongly disagree 
b. disagree 
c. agree 
d. strongly agree 
 
for the HPV vaccine to be effective at preventing HPV related cancers. 
a. strongly disagree 
b. disagree 
c. agree 
d. strongly agree 
 
for the HPV vaccine to be effective at preventing HPV related genital warts. 
a. strongly disagree 
b. disagree 
c. agree 
d. strongly agree 
 
for female students to be vaccinated against HPV. 
a. strongly disagree 
b. disagree 
c. agree 
d. strongly agree 
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for male AND female students to be vaccinated against HPV. 
a. strongly disagree 
b. disagree 
c. agree 
d. strongly agree 
 
for MALE students to be vaccinated against HPV. 
a. strongly disagree 
b. disagree 
c. agree 
d. strongly agree 
 
for preteens to be vaccinated against HPV. 
a. strongly disagree 
b. disagree 
c. agree 
d. strongly agree 
 
for preteens, before they become sexually active, to be vaccinated against HPV. 
a. strongly disagree 
b. disagree 
c. agree 
d. strongly agree 
 
to provide HPV vaccine information to parents. 
a. strongly disagree 
b. disagree 
c. agree 
d. strongly agree 
  
to provide my professional opinion about the HPV vaccine to parents. 
a. strongly disagree 
b. disagree 
c. agree 
d. strongly agree 
 
for parents to vaccinate their child/adolescent against HPV. 
a. strongly disagree 
b. disagree 
c. agree 
d. strongly agree 
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for me to influence parents to vaccinate their child/adolescent against HPV. 
a. strongly disagree 
b. disagree 
c. agree 
d. strongly agree 
 
to be leader in providing HPV vaccine information in the school community. 
a. strongly disagree 
b. disagree 
c. agree 
d. strongly agree 
 
 
Professional Practice: For the following items, please indicate your professional 
practice according to each statement. 
 
During the last academic year I provided. . . 
 
parents with information about HPV vaccination providers (names, addresses, phone 
number). 
a. never  
b. sometimes  
c. often   
d. always 
 
resources (i.e., pamphlets, websites, and flyers) to parents about HPV vaccine. 
a. never  
b. sometimes  
c. often   
d. always 
 
STUDENTS with information about HPV vaccination providers (names, addresses, 
phone number). 
a. never  
b. sometimes  
c. often   
d. always 
 
resources (i.e., pamphlets, websites, and flyers) to STUDENTS about the HPV vaccine 
when the students were IN my office. 
a. never  
b. sometimes  
c. often   
d. always 
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resources (i.e., pamphlets, websites, and flyers) to STUDENTS about the HPV vaccine 
OUTSIDE of my office within the school environment. 
a. never  
b. sometimes  
c. often   
d. always 
 
resources (i.e., pamphlets, websites, and flyers) to STUDENTS about the HPV vaccine 
whether or not students asked for the resources. 
a. never  
b. sometimes  
c. often  
d. always 
 
During the last academic year, I had informational sheets about HPV vaccine in my 
office. 
a. never  
b. sometimes  
c. often   
d. always 
 
During the last academic year approximately how many hours did you. . . 
 
talk directly to parents about the HPV vaccine. 
______ 
 
spend giving educational session(s) (i.e., one day seminars) about the HPV vaccine to 
parents. 
_______ 
 
talk directly to individual STUDENTS about HPV vaccine. 
______ 
 
spend giving educational session(s) during regular class-time specifically about the HPV 
vaccine to STUDENTS. 
________ 
 
Have you spent teaching lesson(s) to STUDENTS that included information about the 
HPV vaccine. 
__________ 
 
 
spend professional time (i.e., time spent on the clock) looking up information about the 
HPV vaccine. 
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__________ 
 
attend continuing education regarding the HPV vaccine.  
__________ 
 
spend looking for methods to provide education to parents about the HPV vaccine. 
__________ 
 
spend looking for methods to provide education to STUDENTS about HPV vaccine. 
__________ 
  
 
Currently, I can provide health education to parents without violating school district 
policy.  
a. strongly disagree 
b. disagree 
c. agree 
d. strongly agree 
 
Currently, my school district supports the health education I provide to parents. 
a. strongly disagree 
b. disagree 
c. agree 
d. strongly agree 
 
Currently, I can provide health education to STUDENTS without violating school 
district policy.  
a. strongly disagree 
b. disagree 
c. agree 
d. strongly agree 
 
Currently, my school district supports the health education I provide to STUDENTS. 
a. strongly disagree 
b. disagree 
c. agree 
d. strongly agree 
 
Currently, any health information I disseminate to STUDENTS or PARENTS must have 
approval from the school district.  
a. strongly disagree 
b. disagree 
c. agree 
d. strongly agree 
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Social Desirability: For the following, please provide your answer. 
 
I’m always willing to admit it when I make a mistake. 
a. True 
b. False 
 
I always try to practice what I preach. 
a. True 
b. False 
 
I like to gossip at times. 
a. True 
b. False 
 
There have been occasions when I took advantage of someone. 
a. True 
b. False 
 
I sometimes try to get even rather than forgive and forget. 
a. True 
b. False 
 
I never resent being asked to return a favor. 
a. True 
b. False 
 
I have never been irked when people expressed ideas very difference from my own. 
a. True 
b. False 
 
I have never deliberately said something that hurt someone’s feelings. 
a. True 
b. False 
 
At times I have really insisted on having things my own way. 
a. True 
b. False 
 
There have been occasions when I felt like smashing things. 
a. True 
b. False 
 
 
 
 144 
 
Knowledge Items: For the following items, please select the correct answer. 
 
The most common sexually transmitted disease is: 
a. HIV 
b. HPV 
c. Herpes 
d. Chlamydia 
 
At least _____% of sexually active people have been infected with HPV at some point in 
their lives. 
a. 10 
b. 25 
c. 50 
d. 80 
 
The MAJORITY of people infected with HPV develop which of the following health 
symptoms: 
a. genital warts 
b. cervical caner 
c. cancer of the throat 
d. no symptoms  
 
LOW risk HPV is known to cause which of the following: 
a. genital warts 
b. cancer 
c. pain during intercourse 
d. urinary tract infection 
 
HIGH risk HPV is known to cause which of the following:  
a. genital warts 
b. cancer 
c. pain during intercourse 
d. urinary tract infection 
 
Women can receive direct testing for HPV through the use of: 
a. Pap smear 
b. pelvic exam 
c. HPV test 
d. a test for HPV does not exist 
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Which test can detect changes in the cervix that may lead to HPV-related cancer? 
a. a Pap smear 
b. pelvic exam 
c. HPV test 
d. such test does not exist 
 
HPV can be spread person-to-person though which of the following contacts? 
a. mutual masturbation  
b. outer-course 
c. opened mouth kissing 
d. oral-to-genital  
 
HPV is known to infect the genitals, but the __________ has also been reported as a site 
of infection. 
a. eyes 
b. ears 
c. throat 
d. nose 
  
The HPV vaccine is available for which age group: 
a. 5 to 22 years 
b. 9 to 26 years 
c. 16 to 32 years 
d. 21 to 38 years 
 
The Gardasil® HPV vaccine is available for: 
a. males only  
b. females only 
c. males and females 
d. teens only 
 
The Cevarix® HPV vaccine is available for: 
a. males only  
b. females only 
c. males and females 
d. teens only 
 
The HPV vaccine requires ____ dose(s).  
a. one 
b. two 
c. three 
d. four 
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The HPV vaccine dose(s) are recommended to be administered: 
a. once 
b. over a four week period 
c. over a three month period 
d. over a six month period 
 
How many different types of HPV vaccines are available on the market? 
a. one 
b. two 
c. three 
d. four 
 
The HPV vaccine is most effective when dose(s) are received before: 
a. sexual contact with any partner 
b. the start of the 6
th
 grade 
c. his/her 9
th
 birthday 
d. his/her 16
th
 birthday 
 
The HPV vaccine is used to: 
a. prevent infection from specific types HPV strains 
b. prevent infection from most HPV strains 
c. treat existing HPV infections 
d. none of the above 
 
The HPV vaccine protects against HPV strains which help prevent: 
a. pelvic inflammatory disease 
b. cervical cancer 
c. uterine cancer 
d. testicular cancer 
 
Which of the following serious side effects from the HPV vaccine has been documented 
and verified by medical personnel? 
a. hair loss 
b. autism 
c. acne 
d. no serious side effects have been documented 
 
Mild side effects that could occur after receiving the HPV vaccine may include: 
a. fever  
b. moodiness 
c. drowsiness 
d. none 
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The HPV vaccine Gardasil® is different from the HPV vaccine Cervarix® in that:  
a. there is no difference 
b. Gardasil® protects ONLY against HPV types 6 and 11 (genital warts) 
c. Gardasil® protects ONLY against HPV types 16 and 18 (cancers) 
d. Gardasil® protects against HPV types 6 and 11 (genital warts) and 16 and 18 
(cancers) 
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APPENDIX B 
TABLE OF KNOWLEDGE INDEX SCORES 
 
Items M SD 
1. The most common sexually transmitted disease is HPV. 
 
0.52 0.50 
2. At least 50% of sexually active people have been  
infected with HPV at some point in their lives. 
0.38 0.49 
 
3. The MAJORITY of people infected with HPV develop no 
symptoms. 
0.48 0.50 
 
4. LOW risk HPV is known to cause genital warts. 
0.83 0.38 
 
5. HIGH risk HPV is known to cause cancer. 
0.92 0.27 
 
6. HPV is known to infect the genitals, but the throat has also been 
reported as a site of infection. 
0.95 0.23 
 
7. The HPV vaccine is available for 9 to 26 years old. 
0.94 0.23 
 
8. The Gardasil® HPV vaccine is available for males and females. 
0.89 0.31 
 
9. The Cevarix® HPV vaccine is available for females only. 
0.49 0.50 
 
10. The HPV vaccine requires three doses. 
0.80 0.40 
 
11. T he HPV vaccine doses are recommended to be administered 
over a six month period. 
0.74 0.44 
 
12. Two different types of HPV vaccines are available on the 
market. 
0.81 0.39 
 
13. The HPV vaccine is used to prevent infection from specific 
HPV strains. 
0.67 0.47 
 
14. The HPV vaccine Gardasil® is different from the HPV vaccine 
Cervarix® in that Gardasil® protects against HPV types 6 and 11 
(genital warts) and 16 and 18 (cancers). 
0.57 0.50 
Note. Italicized text is the correct response for the item. 
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APPENDIX C 
TABLE OF ATTITUDE SCALE SCORES 
 
Items Factor M SD 
1. Important for students to avoid deadly virus 
 
I 10.8 3.6 
2. HPV vaccine is safe 
 
I 12.2 3.0 
3.HPV vaccine is nontoxic 
 
I 12.0 3.1 
4. HPV vaccine has adverse health effects 
 
I 11.3 3.2 
5.HPV has not been on the market long enough to be 
safe 
 
I 8.7 2.8 
6. HPV vaccine prevents HPV 
 
I 11.5 3.1 
7. HPV vaccine prevents cancer 
 
I 11.7 3.2 
8. HPV vaccine prevents genital warts 
 
I 10.4 3.3 
9. Males and females should receive HPV vaccine 
 
I 11.5 3.7 
10.Preteens should receive HPV vaccine I 10.7 4.1 
 
11. Preteens should receive HPV vaccine before they 
become sexually active 
I 11.2 4.0 
 
12. HPV causes major medical problems 
II 9.7 4.1 
 
13. HPV is harmful to health 
II 9.5 4.4 
 
14. HPV weakens the immune system 
II 7.4 3.2 
Note: Factor I = Attitudes about HPV vaccine; Factor II = Attitudes about HPV 
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APPENDIX D 
TABLE OF PERCEPTIONS SCALE SCORES 
 
Items M SD 
1. Providing my professional opinion, I influence parents to 
vaccinate child against HPV 
 
9.1 2.9 
2. Providing information to parents, they will vaccinate child 
against HPV 
 
8.9 3.1 
3. See myself as a leader in providing HPV vaccine information in 
school community 
8.5 3.7 
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APPENDIX E 
TABLE OF PROFESSIONAL PRACTICE SCALE SCORES 
 
Items n Factor M SD 
1.Provided parents with information about HPV 
vaccination providers 
406 I 1.7 0.84 
 
2. Provided resources to parents about HPV 
vaccine 
410 I 1.8 0.86 
 
3. Provided students with information about 
HPV vaccination providers 
401 I 1.5 0.79 
 
4. Provided resources to students about HPV 
vaccine when students were in my office 
404 I 1.6 0.83 
 
5. Provided resources to students about HPV 
vaccine when students were outside of my office 
within the school environment  
405 I 1.4 0.70 
 
6. Provided resources to students about HPV 
vaccine whether or not students asked for 
resources 
402 I 1.4 0.75 
 
7. Had informational sheets about HPV vaccine 
in my office 
412 I 2.3 1.20 
 
8. Can provide health education to parents 
without violating school district policy 
413 II 3.2 0.57 
 
9. School district supports the health education I 
provide to parents 
413 II 3.2 0.46 
 
10. I can provide health education to students 
without violating school district policy 
413 II 3.1 0.61 
 
11. School district supports the health education 
I provide to students 
413 II 3.2 0.31 
Note: Factor I = Providing information and resources about HPV vaccine; Factor II = District supports 
professional practice regarding general health education 
 
 
 
 
